VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaxlert: Peer-reviewed Vaccine Publications in Current Month

From Feb 01, 2025 To Feb 21, 2025:


Bacillus anthracis (Anthrax)

  1. Chuang CC, Chen CC, Chen XA, Lee CY, Chang YH, Tsai MH, Young JJ, Chuang CC. Enhancing the in vivo efficacy of anthrax vaccine using trimethylchitosan covalently coated chitosomes in a single-step microfluidic synthesis International journal of biological macromolecules 304(Pt 1):140689 2025 [PMID: 39914530]

Brucella (Brucellosis)

  1. Zhai Y, Wang H, Sun K, Yuan Y, Yin S, Fang J, Zheng W, Wudong G, Liu X, Yang Y, Zhou D, Liu W, Jin Y, Wang A. Enhancing host defense against Brucella: The immune effect exerted by anti-OMP16 monoclonal antibody International immunopharmacology 148:114142 2025 [PMID: 39930647]
  2. Fathabadi A, Khorashadizadeh F, Darrudi R, Maroosi M. Spatio-temporal analysis of human brucellosis distribution in Neyshabur, Iran from 2015 to 2022, a cross-sectional study PloS one 20(2):e0318503 2025 [PMID: 39965002]
  3. Mallappa A, Kuralayanapalya Puttahonnappa S, Shome R, Patil SS, Amachawadi RG, Mohan KSK, Venkatesh SP, Ramesh V, Sekar YS, Thippeswamy H, Patil AV. Systematic review, Meta-analysis, and Pan-genome analytics predict the surging of Brucella melitensis by China and India-specific strains, elucidating the demand for enhanced preparedness Journal of infection and public health 18(4):102693 2025 [PMID: 39970851]
  4. Ul Hassan S, Khan FA, Shuaib M, Shahid M, Shah SSA, Siddiqui SA, Pokoo-Aikins A, Swelum AA. Investigation into the sero-molecular prevalence of Brucella melitensis in small ruminants in districts Mohmand and Charsadda Khyber Pakhtunkhwa Pakistan PloS one 20(2):e0315206 2025 [PMID: 39919134]
  5. Almuzaini AM, Aljohani ASM, Alajaji AI, Elbehiry A, Abalkhail A, Almujaidel A, Aljarallah SN, Sherif HR, Marzouk E, Draz AA. Seroprevalence of brucellosis in camels and humans in the Al-Qassim region of Saudi Arabia and its implications for public health AMB Express 15(1):22 2025 [PMID: 39918760]
  6. Behzadifar M, Yarahmadi M, Bakhtiari A, Kargar S, Shahabi S, Azari S, Martini M, Behzadifar M. Social network analysis of key stakeholders in Brucellosis prevention in Western Iran Tropical medicine and health 53(1):18 2025 [PMID: 39910632]
  7. Sharif A, Nejad RB, Ghassempour A. Immunoassay-mass spectrometry to identify Brucella melitensis Frontiers in cellular and infection microbiology 15:1531018 2025 [PMID: 39967794]
  8. Khodarovich YM, Elshazly MA, Shell WS, Nassif SA, Devrishov DA, Magomedova SA, Marzanova SN, Deyev SM. Development and Efficacy Evaluation of Multivalent DNA Vaccine against Brucellosis Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections 2025 [PMID: 39899236]
  9. González FM, Bialer MG, Cerruti ML, Estein SM, Ramis LY, Baldi PC, Zorreguieta Á, Ferrero MC. Brucella suis ΔmapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infection Frontiers in immunology 15:1501791 2024 [PMID: 39902052]
  10. Goudarzi T, Abkar M, Fasihi-Ramandi M, Peikar M, Zamanzadeh Z. A comparison between adjuvant and delivering functions of iron oxide and calcium phosphate nanoparticles, using a model protein against Brucella melitensis Clinical and experimental vaccine research 14(1):67-76 2025 [PMID: 39927221]

Burkholderia pseudomallei (Melioidosis)

  1. Noor S, Aljasir MA, Bashir M, Khan K, Ahmad S, Abideen SA, Khan S, Siddique F, Ahmad H, Ghani K, Iqbal M, Irfan M, Khan A, Wei DQ. Multi-scale computational modeling to identify novel chemical scaffolds as trehalose-6-phosphate phosphatase inhibitors to combat Burkholderia pseudomallei In silico pharmacology 13(1):21 2025 [PMID: 39901924]

Coronavirus

  1. Fox A, Fan VY, Kim H, Kang M. Rethinking Trust and Public Health Compliance: Introducing a Trust Continuum for Policy and Practice Health systems and reform 11(1):2457239 2025 [PMID: 39932484]
  2. Poulos C, Buck PO, Ghaswalla P, Rudin D, Kent C, Mehta D. US consumer and healthcare professional preferences for combination COVID-19 and influenza vaccines Journal of medical economics 28(1):279-290 2025 [PMID: 39976591]
  3. Kim S, Park SH, Choi S, Lee W, Choi S, Han S, Han S, Lee DG. Mathematical modelling for vaccine efficacy trials during the future epidemics of emerging respiratory infections Human vaccines & immunotherapeutics 21(1):2467554 2025 [PMID: 39968889]
  4. Kim Y, Taniguchi H, Okuyama K, Kamimoto J, Kawakami K. Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based survey Human vaccines & immunotherapeutics 21(1):2461814 2025 [PMID: 39916584]
  5. Llavona-Ortiz JY, Van Scoy LJ, Fogel B, Pinto C, Graham J, Calo WA. "The big topic is COVID": A qualitative study about changes in HPV vaccine conversations between parents and primary care team members throughout the COVID-19 pandemic Human vaccines & immunotherapeutics 21(1):2460844 2025 [PMID: 39916438]
  6. Balaam MC, Haith-Cooper M. The influence of HARP (The Health Access for Refugees' Project) on vaccine hesitancy in people seeking asylum and refugees in Northern England Global health action 18(1):2457808 2025 [PMID: 39898763]
  7. Bondy S, McClymont E, Av-Gay G, Albert A, Andrade J, Blitz S, Folkes I, Forward L, Fraser E, Grays S, Barrett J, Bettinger J, Bogler T, Boucoiran I, Castillo E, D'Souza R, El-Chaâr D, Fadel S, Kuret V, Ogilvie GS, Poliquin V, Sadarangani M, Scott H, Snelgrove JW, Tunde-Byass M, Money D. Acceptance and attitudes towards COVID-19 vaccination during pregnancy in Canada Human vaccines & immunotherapeutics 21(1):2458353 2025 [PMID: 39898697]
  8. Chávez-Valdés S, Marichal-Rodríguez AK, Chacón-Quintero Y, Martínez-Rosales R, Gómez-Hernández N, Ávila-Díaz L, Vázquez-Arteaga A, González-Formental H, Freyre-Corrales G, Coizeau-Rodríguez E, Guillen G, Lemos-Pérez G. Validation and clinical performance of a non-commercial ELISA for SARS-CoV-2 anti-RBD IgA antibodies Analytical biochemistry 700:115787 2025 [PMID: 39894142]
  9. Shao LT, Wang MM, Wang YM, Li T, Wang F, Xin JR, Zhang X, Li WG, Wang XJ, Wang SQ. Development and application of a high-titer VSV-based HCoV-NL63 pseudovirus system via C-terminal 14 amino acid truncation of spike Biochemical and biophysical research communications 751:151458 2025 [PMID: 39922054]
  10. Hardie I, Marryat L, Murray A, King J, Okelo K, Boardman JP, Lombardo MV, Stock SJ, Wood R, Auyeung B. Early childhood developmental concerns following SARS-CoV-2 infection and COVID-19 vaccination during pregnancy: a Scottish population-level retrospective cohort study The Lancet. Child & adolescent health 9(3):162-171 2025 [PMID: 39978991]
  11. Birtolo LI, Di Pietro G, D'Ascenzo F, Cuccuru G, Fabris E, Merlo M, Andreis A, Cameli M, Improta R, Campo G, De Ferrari GM, Emdin M, Galassi AR, Iliceto S, Imazio M, D'Agata Mottolese B, Porto I, Montisci R, Novo G, Pavan D, Vizza CD, Maestrini V, Basso C, Perrone Filardi P, Sinagra G, Mancone M. COVID-19 vaccines do not raise myocarditis and pericarditis incidence: Italian Society of Cardiology registry Journal of cardiovascular medicine (Hagerstown, Md.) 26(3):143-152 2025 [PMID: 39976066]
  12. Midon MB, Ngatu NR, Kanda K, Hirao T, Miyatake N, Wada K, Nishiyama A. Association between excess mortality due to COVID-19, full vaccination coverage, smoking, hypertension, and gross domestic product per capita/purchasing power parity across 10 Southeast Asian Countries IJID regions 14:100570 2025 [PMID: 39967743]
  13. Bai HJ, Brett-Major D, Du Y, Paritala S, Peters ES, Ratnapradipa KL, Maloney P. Predictors of Persistent COVID-19 Vaccine Refusal Among Previously Infected Patients in Nebraska American journal of public health 115(3):414-424 2025 [PMID: 39938043]
  14. Liu J, Wu Y, Gao GF. A Structural Voyage Toward the Landscape of Humoral and Cellular Immune Escapes of SARS-CoV-2 Immunological reviews 330(1):e70000 2025 [PMID: 39907512]
  15. Dodge MC, Ellervik C, Kataria Y. A Meta-analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Anti-spike Immunoglobulin G Antibody Durability up to 9 Months After Full Vaccination in Adults Clinics in laboratory medicine 45(1):111-136 2025 [PMID: 39892931]
  16. File TM Jr. Vaccines and Other Preventative Strategies for Immunocompromised Pneumonia Clinics in chest medicine 46(1):21-35 2025 [PMID: 39890290]
  17. Kato H, Ichihara N, Saito H, Fujitani S, Ota K, Takahashi Y, Harada T, Hattori T, Komeya M, Hosozawa M, Muto Y, Hori M, Iba A, Iso H, Iso H. Prevalence of erectile dysfunction as long-COVID symptom in hospitalized Japanese patients Scientific reports 15(1):6279 2025 [PMID: 39979349]
  18. Tang X, Sun S, Memedi M, Hiyoshi A, Montgomery S, Cao Y. Cost-effectiveness of preventive COVID-19 interventions: a systematic review and network meta-analysis of comparative economic evaluation studies based on real-world data Journal of global health 15:04017 2025 [PMID: 39977668]
  19. Iqbal J, Hasan Z, Habib MA, Malik AA, Muhammad S, Begum K, Zuberi R, Umer M, Ikram A, Soofi SB, Cousens S, Bhutta ZA. Evidence of rapid rise in population immunity from SARS-CoV-2 subclinical infections through pre-vaccination serial serosurveys in Pakistan Journal of global health 15:04078 2025 [PMID: 39977666]
  20. Zaslavsky ME, Craig E, Michuda JK, Sehgal N, Ram-Mohan N, Lee JY, Nguyen KD, Hoh RA, Pham TD, Röltgen K, Lam B, Parsons ES, Macwana SR, DeJager W, Drapeau EM, Roskin KM, Cunningham-Rundles C, Moody MA, Haynes BF, Goldman JD, Heath JR, Chinthrajah RS, Nadeau KC, Pinsky BA, Blish CA, Hensley SE, Jensen K, Meyer E, Balboni I, Utz PJ, Merrill JT, Guthridge JM, James JA, Yang S, Tibshirani R, Kundaje A, Boyd SD. Disease diagnostics using machine learning of B cell and T cell receptor sequences Science (New York, N.Y.) 387(6736):eadp2407 2025 [PMID: 39977494]
  21. Claireaux M, Elias G, Kerster G, Kuijper LH, Duurland MC, Paul AGA, Burger JA, Poniman M, Olijhoek W, de Jong N, de Jongh R, Wynberg E, van Willigen HDG, Prins M, De Bree GJ, de Jong MD, Kuijpers TW, Eftimov F, van der Schoot CE, Rispens T, Garcia-Vallejo JJ, Ten Brinke A, van Gils MJ, van Ham SM. Deep profiling of B cells responding to various pathogens uncovers compartments in IgG memory B cell and antibody-secreting lineages Science advances 11(8):eado1331 2025 [PMID: 39970201]
  22. Abiona OM, Wang N, Leist SR, Schäfer A, Cockrell AS, Wang L, Bangaru S, Stevens L, Graham RL, Kocher JF, Tsybovsky Y, Kanekiyo M, Kumar A, Morabito KM, Rosen O, Shi W, Werner A, Zhang Y, Ziwawo C, Dzuvor CKO, Palandjian C, Eastman C, Matthews HR, Joseph J, Chappell JD, Kong WP, Mascola JR, Ward AB, Denison MR, Baric R, McLellan JS, Graham BS, Corbett-Helaire KS. MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodies iScience 28(2):111632 2025 [PMID: 39898019]
  23. Della Polla G, Miraglia Del Giudice G, Cirillo R, Sansone V, Napolitano F. Investigating practices and difficulties in communicating with patients about COVID-19 vaccination among healthcare workers in Italy Scientific reports 15(1):6217 2025 [PMID: 39979419]
  24. Ragi ME, Ghattas H, Abi Zeid B, Shamas H, El Salibi NJ, Abdulrahim S, DeJong J, McCall SJ, Caep Study Group T. Legal residency status and its relationship with health indicators among Syrian refugees in Lebanon: a nested cross-sectional study BMJ global health 10(2) 2025 [PMID: 39979019]
  25. Gispen F, Marks KM. Update on Vaccination Recommendations for Adults with HIV Current HIV/AIDS reports 22(1):17 2025 [PMID: 39976870]
  26. Wang H, Zhou W, Wang X, Xiao Y, Tang S, Tang B. Modeling-based design of adaptive control strategy for the effective preparation of 'Disease X' BMC medical informatics and decision making 25(1):92 2025 [PMID: 39972382]
  27. Gundalli S, Poojari S, Balasubramanian A, Das S. Concurrent diphtheria and COVID-19 infection in an unvaccinated child BMJ case reports 18(2) 2025 [PMID: 39971618]
  28. Saravanos G, Teo AKJ, Yam ELY, Chou SC, Chanlivong N, Chanthorn P, Thy C, Sayavong S, Leask J, Yi S, Danchin M, Morgan C, Jenkins K, Kirk M, Macartney K, Coghlan B, Apostol M, Arora D, Gray D, Smart T, Sheel M. Immunisation health workforce capacity building in Southeast Asia: reflections from training programme implementation in Cambodia and Lao PDR BMJ global health 10(2) 2025 [PMID: 39971585]
  29. Cao Y, Li T, Chen H, Zhao Q, Sun J, Grépin KA, Kang JY. Evaluating geographic accessibility to COVID-19 vaccination across 54 countries/regions BMJ global health 10(2) 2025 [PMID: 39971583]
  30. Zhou G, Dael N, Verweij S, Balafas S, Mubarik S, Oude Rengerink K, Pasmooij AMG, van Baarle D, Mol PGM, de Bock GH, Hak E. Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024 European respiratory review : an official journal of the European Respiratory Society 34(175) 2025 [PMID: 39971395]
  31. Iijima K, Akishita M, Endo T, Ichikawa T, Ozaki N, Ogasawara K, Kihara Y, Kuzuya M, Komatsu H, Terasaki H, Doki Y, Noguchi H, Nishi K, Nishimura Y, Haga N, Miyachi M, Yasumura S, Wake J, Arai H. Reconstruction of a resilient and secure community and medical care system in the coronavirus era - English translation of the Japanese opinion released from the Science Council of Japan Geriatrics & gerontology international 2025 [PMID: 39970940]
  32. Galal N, Beshay BY, Soliman O, Ismail MI, Abdelfadil M, El-Hadidi M, Arafa RK, Ibrahim TM. Evaluating the structure-based virtual screening performance of SARS-CoV-2 main protease: A benchmarking approach and a multistage screening example against the wild-type and Omicron variants PloS one 20(2):e0318712 2025 [PMID: 39970175]
  33. Nouanesengsy A, Semesi A, Quach K, Ivanochko D, Byrne W, Hwang M, La Neve M-R, Leon-Ponte M, Litosh A, Wisener N, Adeli K, Campigotto A, Grunebaum E, McGeer A, Moraes TJ, Sepiashvili L, Upton J, Julien J-P, Allen U. Persistence and decay of neutralizing antibody responses elicited by SARS-CoV-2 infection and hybrid immunity in a Canadian cohort Microbiology spectrum :e0133324 2025 [PMID: 39969224]
  34. Sheng-Kai Ma K, Shen CH, Chiang MH, Blumenthal KG, Chen ST. Severe Cutaneous Adverse Reactions Following Vaccination: A Systematic Review and Meta-analysis The journal of allergy and clinical immunology. In practice 2025 [PMID: 39978545]
  35. Zhao F, Zhang Y, Zhang Z, Chen Z, Wang X, Wang S, Li R, Li Y, Zhang Z, Zheng W, Wang Y, Zhang Z, Wu S, Yang Y, Zhang J, Zai X, Xu J, Chen W. Epitope-focused vaccine immunogens design using tailored horseshoe-shaped scaffold Journal of nanobiotechnology 23(1):119 2025 [PMID: 39966941]
  36. Jiang Y, Li Y, Huang Y. Alterations in menstrual characteristics and associated factors in Chinese women post SARS-CoV-2 infection: a cross-sectional study BMC women's health 25(1):69 2025 [PMID: 39966921]
  37. Zhang X, Luan Y, Tang Y, Lau MMC, Yu Y, Gu J, Lau JTF. Perceived social support and self-stigma as factors of COVID-19 booster vaccination behavior and intention via cognitive coping and emotion regulation among people infected with COVID-19 in Hong Kong BMC public health 25(1):659 2025 [PMID: 39966881]
  38. Riedmann U, Chalupka A, Richter L, Sprenger M, Rauch W, Schenk H, Krause R, Willeit P, Oberacher H, Høeg TB, Ioannidis JPA, Pilz S. Estimates of SARS-CoV-2 Infections and Population Immunity After the COVID-19 Pandemic in Austria: Analysis of National Wastewater Data The Journal of infectious diseases 2025 [PMID: 39964838]
  39. Tan JS, Vathsala A, Sran HK, D'Costa MR, Chang ZY, Wong ETY. Perceptions and attitudes of kidney transplant recipients towards SARS-CoV-2 vaccination: a single-centre study Singapore medical journal 2025 [PMID: 39963766]
  40. Yang J, Wang J, Zhang H, Li S, Wang X, Baimanov D, Zhang Z, Li Y, Yu P, Zhang X, Wang L. Rapid Detection of Spike Protein Receptor Binding Region of SARS-CoV-2 and Its Variants Using a Nanosheet Probe Analytical chemistry 97(6):3729-3738 2025 [PMID: 39924735]
  41. Nguyen HT, Garg R, Kroeker A, Gerdts V, Falzarano D, Liu Q. Immunogenicity of virus-like particle vaccine candidates against SARS-CoV-2 infection Access microbiology 7(2) 2025 [PMID: 39967742]
  42. Soltani S, Moradinazar M, Karamimatin B, Gouya MM, Zahraei SM, Moradi G, Chehri O, Soofi M, Shadmani FK, Kalantari M, Najafi F. Monitoring and active surveillance of adverse events following the booster dose of AZD1222 vaccine in people vaccinated with Sinopharm BBIBP-CorV: a cohort study BMC public health 25(1):650 2025 [PMID: 39962455]
  43. Halperin DM, Whitfield K, Bettinger JA, Orhierhor M, Salter KL, Selig BM, Mack A, Condran BR, Davis A, Salyzyn C, Parsons JA, Kervin M, Halperin SA. Unveiling the impact: understanding long-term care workers' experiences and their perceptions of resident challenges amidst the COVID-19 pandemic BMC geriatrics 25(1):108 2025 [PMID: 39962421]
  44. Zheng B, Gonçalves BP, Deng P, Wang W, Tian J, Liang X, Yao Y, Xue C. Protection afforded by post-infection SARS-CoV-2 vaccine doses: A cohort study in Shanghai eLife 13 2025 [PMID: 39960759]
  45. Obakachi VA, Nchiozem-Ngnitedem VA, Govender KK, Govender PP. In silico exploration of natural xanthone derivatives as potential inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication and cellular entry Journal of computer-aided molecular design 39(1):7 2025 [PMID: 39960606]
  46. Nakazawa E, Uchimura T, Ohyama R, Togashi H, Inaba A, Shiga K, Ito S. Two adolescents with frequently relapsing nephrotic syndrome newly diagnosed after SARS-CoV-2 vaccination: case report and literature review CEN case reports 2025 [PMID: 39960599]
  47. . Correction to: Natural Boosting and the Immunogenicity of the XBB.1.5 Monovalent Vaccine in the Coronavirus Disease 2019 Endemic Era: A Longitudinal Observational Study The Journal of infectious diseases 2025 [PMID: 39960372]
  48. Loyal L, Braun J, Reimer U, Meyer-Arndt L, Henze L, Kruse B, Dingeldey M, Mangold M, Behrens J, Tober Lau P, Michel J, Grossegesse M, Schnatbaum K, Wenschuh H, Johannis W, Di Cristanziano V, Nitsche A, Klein F, Sander LE, Thiel A. Hybrid immunity-based induction of durable pan-endemic-coronavirus immunity in the elderly Cell reports 44(2):115314 2025 [PMID: 39960834]
  49. Hagiya H, Fujita Y, Kiguchi T, Manabe Y. Intention and potential determinants of COVID-19 vaccination among healthcare workers at a single university hospital in Japan, 2024-2025 pre-season Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 31(3):102660 2025 [PMID: 39956368]
  50. Feng B, Li C, Zhang Z, Huang Y, Liu B, Zhang Z, Luo J, Wang Q, Yin L, Chen S, He P, Xiong X, Zhao J, Niu X, Chen Z, Chen L. A shark-derived broadly neutralizing nanobody targeting a highly conserved epitope on the S2 domain of sarbecoviruses Journal of nanobiotechnology 23(1):110 2025 [PMID: 39955548]
  51. Jiang J, Lam KF, Lau EHY, Yin G, Lin Y, Cowling BJ. Joint analysis of time-varying effect of vaccine and antiviral drug for preventing severe complications and mortality Scientific reports 15(1):5640 2025 [PMID: 39955370]
  52. Hasan Z, Masood KI, Veldhoen M, Qaiser S, Alenquer M, Akhtar M, Balouch S, Iqbal J, Wassan Y, Hussain S, Feroz K, Muhammad S, Habib A, Kanji A, Khan E, Mian AA, Hussain R, Amorim MJ, Bhutta ZA. Pre-existing IgG antibodies to HCoVs NL63 and OC43 Spike increased during the pandemic and after COVID-19 vaccination Heliyon 11(3):e42171 2025 [PMID: 39916832]
  53. Rybak A, Ouldali N, Werner A, Casha P, Robert B, de Pontual L, Béchet S, Cahn-Sellem F, Angoulvant F, Cohen R, Levy C. Characteristics of Children Hospitalized for Acute COVID-19 in France From February 2020 to December 2023 The Pediatric infectious disease journal 2025 [PMID: 39961110]
  54. Zaki DP, Zeng E, Duet ML, Stone CE, Giglio RS, Tapp MW, Llull R, Calder BW, Robinson JM. Impact of COVID-19 on Thrombotic Complications in Microsurgery: Deep Inferior Epigastric Perforator Flap Outcomes Amid Pandemic Plastic and reconstructive surgery. Global open 13(2):e6544 2025 [PMID: 39958714]
  55. Smith DS, Postma M, Fisman D, Mould-Quevedo J. Cost-effectiveness models assessing COVID-19 booster vaccines across eight countries: A review of methods and data inputs Vaccine 51:126879 2025 [PMID: 39956089]
  56. Güzel I, Öztürk G, Appak Ö, Çağlayan D, Süner AF, Irmak Ç, Türe N, Işik E, Çelik M, Ergör G, Ergör A, Demiral Y, Alp Çavuş S, Kilic B, Sayiner A. Neutralizing and binding antibody dynamics following primary and booster COVID-19 vaccination among healthcare workers BMC infectious diseases 25(1):218 2025 [PMID: 39953414]
  57. Soussand F, Abdou AY, Sanchez M, Huynh BT, Giese C, Tran-Kiem C, Béraud G, Guillemot D, Cauchemez S, Opatowski L, Bosetti P. Evolution of social contacts patterns in France over the SARS-CoV-2 pandemic: results from the SocialCov survey BMC infectious diseases 25(1):224 2025 [PMID: 39953405]
  58. Barket SE, Karim MR, Salan MSA. Bayesian spatio-temporal disease mapping of COVID-19 cases in Bangladesh PloS one 20(2):e0316621 2025 [PMID: 39951472]
  59. Soni DK, Cabrera-Luque J, Kar S, Ahmed A, Sen C, Devaney J, Biswas R. Suppression of miR-155 Attenuates Lung Cytokine Storm Induced by SARS-CoV-2 Infection Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2025 [PMID: 39950973]
  60. Yu R, Zhang L, Bai Y, Zhou P, Yang J, Wang D, Wei L, Zhang Z, Yan C, Wang Y, Guo H, Pan L, Yuan L, Liu X. Development of a nanobody-based competitive enzyme-linked immunosorbent assay for the sensitive detection of antibodies against porcine deltacoronavirus Journal of clinical microbiology :e0161524 2025 [PMID: 39950715]
  61. van Buchem-Post NF, Ouwerkerk W, Stalman EW, van Dam KPJ, Wieske L, Bekkenk MW, Wolkerstorfer A, Spuls P, Musters AH, Bosma AL, Hijnen DJ, Eftimov F, Luiten RM, van Kempen ZLE, Stalman EW, Steenhuis M, Kummer LYL, van Dam KPJ, Ten Brinke A, van Ham SM, Kuijpers T, Rispens T, Eftimov F, Wieske L, Killestein J, Kooi AJV, Raaphorst J, Zwinderman AHK, Löwenberg M, Volkers AG, D'Haens GRAM, Takkenberg RB, Tas SW, Hilhorst ML, Vegting Y, Bemelman FJ, Verstegen NJM, Fernandez L, Keijzer S, Keijser JBD, Cristianawati O, Voskuyl AE, Broens B, Sanchez AP, Nejentsev S, Mirfazeli ES, Wolbink GJ, Boekel L, Rutgers BA, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart R, Teng Y, Busch MH, Brusse E, van Doorn PA, Baars M, Schreurs C, van der Pol WL, Goedee HS, van Els CACM, de Wit J. Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy The Journal of dermatology 2025 [PMID: 39950702]
  62. Kamelian K, Sievers B, Chen-Xu M, Turner S, Cheng MTK, Altaf M, Kemp SA, Abdullahi A, Csiba K, Collier DA, Mlcochova P, Meng B, Jones RB, Smith D, Bradley J, Smith KGC, Doffinger R, Smith RM, Gupta RK. Humoral responses to SARS-CoV-2 vaccine in vasculitis-related immune suppression Science advances 11(7):eadq3342 2025 [PMID: 39937891]
  63. Yang J, Rai KK, Alfred T, Massey L, Massey O, McGrath L, Andersen KM, Tritton T, Tsang C, Butfield R, Reynard C, Mendes D, Nguyen JL. The impact of COVID vaccination on incidence of long COVID and healthcare resource utilisation in a primary care cohort in England, 2021-2022 BMC infectious diseases 25(1):214 2025 [PMID: 39948466]
  64. Sumsuzzman DM, Ye Y, Wang Z, Pandey A, Langley JM, Galvani AP, Moghadas SM. Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis BMC infectious diseases 25(1):215 2025 [PMID: 39948450]
  65. Zhao C, Zhang T, Guo L, Sun S, Miao Y, Yung CF, Tomlinson J, Stolyarov K, Shchomak Z, Poovorawan Y, Nokes DJ, Muñoz-Almagro C, Mandelboim M, Keck JW, Langley JM, Heikkinen T, Deng J, Colson P, Chakhunashvili G, Caballero MT, Bont L, Feikin DR, Nair H, Wang X, Li Y. Characterising the asynchronous resurgence of common respiratory viruses following the COVID-19 pandemic Nature communications 16(1):1610 2025 [PMID: 39948338]
  66. Sillence E, Branley-Bell D, Moss M, Briggs P. A Model of Trust in Online COVID-19 Information and Advice: Cross-Sectional Questionnaire Study JMIR infodemiology 5:e59317 2025 [PMID: 39946705]
  67. Morisaki S, Yoshii K, Tsuchida S, Oda R, Takahashi K. Impact of COVID-19 on orthopedic trauma patients from 2021 to 2022 when restrictions were lifted, compared with the pre-pandemic period Journal of orthopaedic surgery and research 20(1):158 2025 [PMID: 39940006]
  68. Ali S, Azarian T. An ecological study of COVID-19 outcomes among Florida counties BMC public health 25(1):579 2025 [PMID: 39939852]
  69. Hamzaoui H, Shaum A, Cherkaoui I, Moussa LA, Sefiani H, Talibi I, Benabdallah G, Salman O, Ferrey S, Soulaymani Bencheikh R. Assessment of Pharmacovigilance Across University Hospitals in Morocco Drug safety 2025 [PMID: 39939518]
  70. Hwang HS, Lee H, Yoon SY, Kim JS, Jeong K, Kronbichler A, Kim HJ, Kim MS, Rahmati M, Shin JY, Choi A, Shin JI, Lee J, Yon DK. Global burden of vaccine-associated kidney injury using an international pharmacovigilance database Scientific reports 15(1):5177 2025 [PMID: 39939373]
  71. Rodriguez-Torres JF, Romero-Ibarguengoitia ME, Garza-Silva A, Rivera-Cavazos A, Hurtado-Cabrera M, Kalife-Assad R, Villarreal-Parra DL, Loose-Esparza A, Gutierrez-Arias JJ, Mata-Porras YG, Ojeda-Salazar DA, Morales-Rodriguez DP, Sanz-Sánchez MÁ, Gonzalez-Cantú A. Association between Mexican vaccination schemes and the duration of long COVID syndrome symptoms Scientific reports 15(1):5301 2025 [PMID: 39939334]
  72. Wang JJ, Warkentin TE, Schönborn L, Wheeler MB, Geerts WH, Costedoat-Chalumeau N, Gendron N, Ene G, Lozano M, Langer F, Lindhoff-Last E, Budde K, Chataway T, Troelnikov A, Sheppard JI, Zhang Y, Arnold DM, Gordon TP, Thiele T, Greinacher A, Nazy I. VITT-like Monoclonal Gammopathy of Thrombotic Significance The New England journal of medicine 2025 [PMID: 39938091]
  73. Gelyi EK, Azaare J, Bonso NK, Kpordoxah MR, Aninanya GA. Impact of perceived factors of coronavirus infection on COVID-19 vaccine uptake among healthcare workers in Ghana-Evidence from a cross-sectional analysis PloS one 20(2):e0318662 2025 [PMID: 39937845]
  74. Shehzadi K, Kalsoom I, Yu MJ, Liang JH. Design and in-silico evaluation of PNA-based novel pronucleotide analogues targeting RNA-dependent RNA polymerase to combat COVID-19 Journal of biomolecular structure & dynamics :1-23 2025 [PMID: 39937582]
  75. Furusawa Y, Kiso M, Uraki R, Sakai-Tagawa Y, Nagai H, Koga M, Kashima Y, Hojo M, Iwamoto N, Iwatsuki-Horimoto K, Ohmagari N, Suzuki Y, Yotsuyanagi H, Halfmann PJ, Kamitani W, Yamayoshi S, Kawaoka Y. Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior virus growth at low temperatures Journal of virology :e0221724 2025 [PMID: 39936915]
  76. Nguyen TL, Nguyen TB, Kim H. Computational identification of B and T-cell epitopes for designing a multi-epitope vaccine against SARS-CoV-2 spike glycoprotein Journal of structural biology :108177 2025 [PMID: 39947305]
  77. Athina P, Stavroula L, Despoina Zoe MT, Stavroula K, Maria KG. The Clinical Burden of SARS-CoV-2 Compared to Influenza A in the Same Cohort of Paediatric Outpatients; Increased Influenza Severity and Potential Insights Journal of paediatrics and child health 2025 [PMID: 39935033]
  78. Zhang K, Hunyadi JV, de Oliveira Otto MC, Lee M, Zhang Z, Ramphul R, Yamal JM, Yaseen A, Morrison AC, Sharma S, Rahbar MH, Zhang X, Linder S, Marko D, Roy RW, Banerjee D, Guajardo E, Crum M, Reininger B, Fernandez ME, Bauer C. Increasing COVID-19 Testing and Vaccination Uptake in the Take Care Texas Community-Based Randomized Trial: Adaptive Geospatial Analysis JMIR formative research 9:e62802 2025 [PMID: 39935005]
  79. Humphrey TJL, Qian W, Chen-Xu M, Dowling F, Gatley K, Adhikari R, Hensman T, Stockley L, Bassi A, Bathla N, Dasgupta I, Dosanjh DPS, Jellingsø M, Sørensen P, Jensen ML, Callesen AW, Bradley JR, Jha V, Sommer MOA, Hiemstra TF, Smith RM. Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V platform trial BMC infectious diseases 25(1):204 2025 [PMID: 39934669]
  80. Sasaki E, Asanuma H, Momose H, Maeyama JI, Moriyama S, Nagata N, Suzuki T, Hamaguchi I, Hasegawa H, Takahashi Y. Calboxyvinyl polymer adjuvant enhances respiratory iga responses through mucosal and systemic administration NPJ vaccines 10(1):28 2025 [PMID: 39934182]
  81. Van Loy B, Pujol E, Kamata K, Lee XY, Bakirtzoglou N, Van Berwaer R, Vandeput J, Mestdagh C, Persoons L, De Wijngaert B, Goovaerts Q, Noppen S, Jacquemyn M, Ahmadzadeh K, Bernaerts E, Martín-López J, Escriche C, Vanmechelen B, Krasniqi B, Singh AK, Daelemans D, Maes P, Matthys P, Dehaen W, Rozenski J, Das K, Voet A, Vázquez S, Naesens L, Stevaert A. A guanidine-based coronavirus replication inhibitor which targets the nsp15 endoribonuclease and selects for interferon-susceptible mutant viruses PLoS pathogens 21(2):e1012571 2025 [PMID: 39932973]
  82. Dryden-Peterson S, Kim A, Caniglia EC, Joyce MR, Rubins D, Kim AY, Fangman J, Baden LR, Woolley AE. Severe outcomes of COVID-19 among adults with increased risk conditions: A population-based observational study PloS one 20(2):e0316529 2025 [PMID: 39932956]
  83. Saito R, Tsugawa S. Understanding Citizens' Response to Social Activities on Twitter in US Metropolises During the COVID-19 Recovery Phase Using a Fine-Tuned Large Language Model: Application of AI Journal of medical Internet research 27:e63824 2025 [PMID: 39932775]
  84. Suzuki Okutani M, Okamura S, Gis T, Sasaki H, Lee S, Kashiwabara A, Goto S, Matsumoto M, Yamawaki M, Miyazaki T, Nakagawa T, Ikawa M, Kamitani W, Takekawa S, Yamanishi K, Ebina H. Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms eLife 13 2025 [PMID: 39932490]
  85. Lyu C, Liang X, Jiang J, Wang F, An R, Yang J, Wang D. Inactivation of porcine epidemic diarrhea virus as a SARS-CoV-2 surrogate at sub-zero temperatures by isochoric freezing Cryobiology 118:105209 2025 [PMID: 39904481]
  86. Trimbake D, Singh D, K YG, Babar P, S VD, Tripathy AS. Durability of Functional SARS-CoV-2-Specific Immunological Memory and T Cell Response up to 8-9 Months Postrecovery From COVID-19 Journal of immunology research 2025:9743866 2025 [PMID: 39963186]
  87. Ma C, Smith TE, Culhane DP. Generalized Anxiety Disorder Prevalence and Disparities Among U.S. Adults: The Roles Played by Job Loss, Food Insecurity, and Vaccinations During the COVID-19 Pandemic The journals of gerontology. Series B, Psychological sciences and social sciences 80(3) 2025 [PMID: 39932287]
  88. Kinoshita R, Miyamoto S, Suzuki T, Suzuki M, Yoneoka D. Interpreting the Influence of Using Blood Donor Residual Samples for SARS-CoV-2 Seroprevalence Studies in Japan: Cross-Sectional Survey Study JMIR public health and surveillance 11:e60467 2025 [PMID: 39931010]
  89. Xiao Y. The internet usage increases fear of infection with Covid-19 Scientific reports 15(1):4936 2025 [PMID: 39930035]
  90. Mameli C, Valsecchi C, Cereda D, Scarioni S, Barcellini L, Boriello C, Bonfanti R, Brambilla I, Calcaterra V, Calzi E, Cardani R, Cogliardi A, Felappi B, Florini G, Frontino G, Guerraggio LP, Hajro A, Macedoni M, Macellaro P, Petitti A, Pistone C, Provero C, Radaelli S, Redaelli FC, Rigamonti A, Scaramuzza A, Sordelli S, Spiri D, Pelliccia C, Zampolli M, Zuccotti GV. Type 1 diabetes incidence during COVID-19 pandemic has not been influenced by COVID-19 vaccination in northern Italy region, Lombardy PloS one 20(2):e0316340 2025 [PMID: 39928666]
  91. Alshanik F, Khasawneh R, Dalky A, Qawasmeh E. Unveiling Topics and Emotions in Arabic Tweets Surrounding the COVID-19 Pandemic: Topic Modeling and Sentiment Analysis Approach JMIR infodemiology 5:e53434 2025 [PMID: 39928401]
  92. Soto G, Romero C, Gonzales M, La Rosa S, Ponce D, Tecco A, Vega D, Silva M, Llanos-Cuentas A, Matos E, Chavez Perez V, Castillo ME, Castro JC, Prouty MG, Neyra J. Influenza Virus Surveillance in Healthcare Personnel in Peru: NAMRU SOUTH Experience and Perspective The Journal of infectious diseases 231(Supplement_1):S25-S30 2025 [PMID: 39928380]
  93. da Costa FADS, Assato PA, Tasca KI, de Moraes LN, Dos Santos Figueiredo DB, Ribeiro G, Lima ARJ, Sampaio SC, Elias Sabbaga MCQB, Fortaleza CMCB, de Souza-Neto JA, Grotto RMT. Genomic and epidemiological surveillance of SARS-CoV-2 variants during the pre-mass vaccination period in Botucatu, Brazil Virus genes 2025 [PMID: 39928246]
  94. Cao X, Liu Y, Tong W, Qin W, Yang X, Yu H, Zheng H, Zhang W, Tong G, Kong N, Shan T. POLM inhibits porcine epidemic diarrhea virus replication by degrading multiple viral structural proteins Journal of virology :e0227824 2025 [PMID: 39927776]
  95. Yeh JT, Wang YF, Tzeng YS, Chen SP, Pan LH, Wang SJ. Exploring the impact of acute SARS-CoV-2 infection on headache pattern in patients with migraine: A novel Bayesian analysis Headache 2025 [PMID: 39927465]
  96. Kong TK. Dermatomyositis following COVID-19 vaccination Hong Kong medical journal = Xianggang yi xue za zhi 2025 [PMID: 39925189]
  97. Lu Y, Li AQ, Shen F, He WQ, Yu SH, Zhao YB, Feng XL, Li MH, Ouyang S, Zheng YT, Pang W. Recombinant protein HR212 targeting heptad repeat 2 domain in spike protein S2 subunit elicits broad-spectrum neutralizing antibodies against SARS-CoV-2 and its variants MedComm 6(2):e70088 2025 [PMID: 39931737]
  98. Shinzato A, Hibiya K, Nishiyama N, Ikemiyagi N, Arakaki W, Kami W, Nabeya D, Ideguchi S, Nakamura H, Furugen M, Miyagi K, Nakamatsu M, Haranaga S, Kinjo T, Fujita J, Nakamura K, Yamamoto K. Unseasonal respiratory syncytial virus epidemics during the COVID-19 pandemic: relationship between climatic factors and epidemic strain switching International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases :107833 2025 [PMID: 39929319]
  99. Feng R, Xue RY, Liu C, Li GC, Deng Y, Jin Z, Liu JY, Zhang SS, Cheng H, Guo MY, Zou QM, Li HB. RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2 Journal of nanobiotechnology 23(1):97 2025 [PMID: 39923096]
  100. Waldman JS, Alonzo J, Mann-Jackson L, Aguilar-Palma SK, Garcia M, Smart BD, Rhodes SD. Perspectives of the COVID-19 pandemic and vaccination among racially and ethnically diverse gay, bisexual, and other men who have sex with men with and without HIV in the US South: findings from qualitative individual in-depth interviews BMC infectious diseases 25(1):193 2025 [PMID: 39923031]
  101. Shigayeva A, Kandel C, Farooqi L, Zhong Z, Gingras AC, Coleman BL, Gilbert L, Gold WL, Major M, Mazzulli T, Mubareka S, Vojicic J, Yang J, Zhang P, Martin C, Kyaw MH, McLaughlin JM, McGeer A. Early COVID-19 and protection from Omicron in a highly vaccinated population in Ontario, Canada: a matched prospective cohort study BMC infectious diseases 25(1):194 2025 [PMID: 39923009]
  102. Bansal A, Trieu MC, Eriksson EM, Zhou F, McVernon J, Brokstad KA, Cox RJ. SARS-CoV-2 infection rates and associated risk factors in healthcare workers: systematic review and meta-analysis Scientific reports 15(1):4705 2025 [PMID: 39922967]
  103. Devaraj AR, Marianthiran VJ. Advancements in Viral Genomics: Gated Recurrent Unit Modeling of SARS-CoV-2, SARS, MERS, and Ebola viruses Revista da Sociedade Brasileira de Medicina Tropical 58:e004012024 2025 [PMID: 39936709]
  104. Sanghar GK, Teuber M, Ravindran R, Keller EJ, Raffuse S, Hernandez P, Linderholm A, Echt G, Franzi L, Tuermer-Lee K, Juarez M, Albertson T, Khan I, Haczku A. Real-life observation of wildfire-smoke impaired COVID-19 vaccine immunity The Journal of allergy and clinical immunology 2025 [PMID: 39924122]
  105. Kim SE, Noh JJ, Lee YY. Coronavirus disease vaccine linked menstrual changes: mobile application study Obstetrics & gynecology science 2025 [PMID: 39923754]
  106. Abbad A, Yueh J, Yellin T, Singh G, Carreño JM, Clark JJ, Muramatsu H, Tiwari S, Bhavsar D, Alzua GP, Pardi N, Simon V, Krammer F. Co-administration of seasonal quadrivalent influenza and COVID-19 vaccines leads to enhanced immune responses to influenza virus and reduced immune responses to SARS-CoV-2 in naive mice Vaccine 50:126825 2025 [PMID: 39921982]
  107. Tabrizi JS, Letaief M, Mashhadi Abdolahi H, Rezapour R, Alboksmaty A, Farahbakhsh M. Safety of health workers during the COVID-19 pandemic and beyond: piloting WHO framework in Iran Journal of health, population, and nutrition 44(1):29 2025 [PMID: 39920792]
  108. Liu X, Xin Y, Zhang L, Wu Y, Jing S, Dai Z, Ren T, Liu X, Fu J, Chen X, Xiao W, Wang H, Huang Y, Wang W, Gu X, Ma L, Zhang S, Yu Y, Li L, Gao T, Zhao T, Qu Y, Liu X, Su X, Qiao Y. Uptake and hesitancy of the second booster dose of COVID-19 vaccine among the general population in China after the surge period of the COVID-19 pandemic: a large-scale national study BMC public health 25(1):503 2025 [PMID: 39920639]
  109. Martinez-Cajas JL, Jolly A, Gong Y, Evans G, Perez-Patrigeon S, Stoner B, Guan TH, Alvarado B. Risk of SARS-CoV-2 infection before and after the Omicron wave in a cohort of healthcare workers in Ontario, Canada BMC infectious diseases 25(1):183 2025 [PMID: 39920611]
  110. Yu J, Bekerian DA. From information to action: modelling social and cognitive factors in health decisions BMC public health 25(1):508 2025 [PMID: 39920594]
  111. Njagu R, Freedy K, Brucker A, Feng K, Lunn S, Greene M, Swamy GK, Dotters-Katz S. Impact of Coronavirus Disease-2019 on Influenza and Tdap Vaccination Rates in Pregnant Patients American journal of perinatology 2025 [PMID: 39919807]
  112. Jiang Y, Sanyal M, Hussein NA, Baghdasaryan A, Zhang M, Wang F, Ren F, Li J, Zhu G, Meng Y, Adamska JZ, Mellins E, Dai H. A SARS-CoV-2 vaccine on an NIR-II/SWIR emitting nanoparticle platform Science advances 11(6):eadp5539 2025 [PMID: 39919189]
  113. Salamony A, Abdelsalam M, Elguindy N, Roshdy WH, Youssef A, Shamikh Y. Vitamin D as an Adjuvant Immune Enhancer to SARS-Cov-2 Vaccine Current microbiology 82(3):122 2025 [PMID: 39918738]
  114. Jensen CB, Hansen KT, Nielsen CM, Hansen SN, Nielsen H, Rask CU, Fink P, Dantoft TM, Jørgensen T, Bech BH, Thysen SM, Rytter D. Cohort profile: The BiCoVac cohort - a nationwide Danish cohort to assess short and long-term symptoms following COVID-19 vaccination European journal of epidemiology 2025 [PMID: 39918723]
  115. Kulkarni D, Lee B, Ismail NF, Rahman AE, Spinardi J, Kyaw MH, Nair H. Incidence, severity, risk factors and outcomes of SARS-CoV-2 reinfections during the Omicron period: a systematic review and meta-analysis Journal of global health 15:04032 2025 [PMID: 39916552]
  116. Li S, Li R, Li Y, Hu Y, Liu Y, Qin J, Qin Z, Feng Q, Sheng Z, Li C, Peng J. Combination of Evans syndrome and COVID-19: a systematic review of reported cases Blood transfusion = Trasfusione del sangue 2025 [PMID: 39949024]
  117. Barozi V, Tastan Bishop Ö. Impact of African-Specific ACE2 Polymorphisms on Omicron BA.4/5 RBD Binding and Allosteric Communication Within the ACE2-RBD Protein Complex International journal of molecular sciences 26(3) 2025 [PMID: 39941135]
  118. Sun FY, Liu W, Ding SJ, Yan FR, Wang J, Peng ZH. [Innovative design and statistical considerations in vaccine clinical trials] Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 59(2):254-259 2025 [PMID: 39939000]
  119. Marron L, Duffy R, O'Donnell J, Domegan L. An evaluation of the severe acute respiratory infection surveillance system in Ireland BMC public health 25(1):492 2025 [PMID: 39915743]
  120. Simms I, Charlett A, Colón-González FJ, Blomquist PB, Lake IR, Zaidi A, Shadwell S, Sedgwick J, Paranthaman K, Vivancos R. Adapting the Flexible Farrington Algorithm for daily situational awareness and alert system to support public health decision-making during the SARS-CoV-2 epidemic in England Epidemiology and infection 153:e28 2025 [PMID: 39911069]
  121. Gan CLS, Chung SJ, Ho QY, Tan TT, Tan BH, Liew IT, Tien CS, Thangaraju S, Kee T. Predictors of moderate, severe, and critical COVID-19 infection in a largely vaccinated kidney transplant recipient cohort during the Omicron era: the importance of timely booster vaccinations and early presentation to care Clinical transplantation and research 2025 [PMID: 39909823]
  122. Abaate TJ, Buowari DY, Agiri UA Jr, Inimgba T, Ogbonna VI, Onyeaghala C, Worgu GO, Somiari A, Ezebuiro EI, Onuah IA. Prevalence of COVID-19 Vaccine Hesitancy Among Healthcare Workers in Nigeria: A Systematic Review and Meta-Analysis International journal of public health 70:1607655 2025 [PMID: 39973941]
  123. Rojas G, Jain A, Bany-Mohammed F, Felgner P, Aslam M, Uy CC. Concordance of maternal and cord blood SARS-COV-2 immunoglobulin seropositivity after COVID-19 infection or vaccination in pregnancy Journal of neonatal-perinatal medicine :19345798251315385 2025 [PMID: 39973524]
  124. Smilie C, Nandeibam SK, Singh CS, Devi KR, Devi YB, Devi YB, Akham N, Nandeibam SL. Seroprevalence of SARS-CoV-2 infection among hospitalized children at a tertiary care center in North-East India Journal of tropical pediatrics 71(2) 2025 [PMID: 39965169]
  125. Lovett D, Woodcock T, Naude J, Redhead J, Majeed A, Aylin P. Evaluation of a pragmatic approach to predicting COVID-19-positive hospital bed occupancy BMJ health & care informatics 32(1) 2025 [PMID: 39914853]
  126. Hiremath JB, Swathi M, Ramamoorthy R, Shijili M, Sharma D, Hemadri D, Chethankumar HB, Suresh KP, Patil SS, Nayakvadi S, Satheesha SP, Shome BR, Gulati BR. First detection and molecular characterization of porcine epidemic diarrhea virus (PEDV) in India: evidence of a new variant in Karnataka Virology journal 22(1):28 2025 [PMID: 39910537]
  127. La YJ, Oh WS, Kim C, Lim MN, Jeon YD. Clinical outcomes of early remdesivir administration in hospitalized patients at high risk for severe COVID-19 during the Omicron wave BMC infectious diseases 25(1):167 2025 [PMID: 39910500]
  128. Chemaitelly H, Ayoub HH, Coyle P, Tang P, Hasan MR, Yassine HM, Al Thani AA, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron Nature 2025 [PMID: 39910292]
  129. Patel MN, Tiwari S, Wang Y, O'Neill S, Wu J, Omo-Lamai S, Espy C, Chase LS, Majumder A, Hoffman E, Shah A, Sárközy A, Katzen J, Pardi N, Brenner JS. Safer non-viral DNA delivery using lipid nanoparticles loaded with endogenous anti-inflammatory lipids Nature biotechnology 2025 [PMID: 39910195]
  130. Shehab S, Anouti L, Boutros CF, Radi C, Baasiri SE, Badih A, Korman R, Masri ME, Alwan J, Monzer M, Bitar Y, Kassem M, Naser M, Salameh Y, Khafaja S, Ghosn MB, Al Hamod D, Ghadban S, Ghanem S, Dbaibo GS. End of Pandemic Parental Hesitancy Towards Pediatric COVID-19 Vaccination: A Cross-sectional Survey at Two Lebanese Tertiary Hospitals Journal of epidemiology and global health 15(1):15 2025 [PMID: 39910010]
  131. Odd D, Stoianova S, Williams T, Thursby-Pelham A, Ladhani SN, Oligbu G, Fleming P, Luyt K. Deaths in children in England from SARS-CoV-2 infection during the first 2 years of the pandemic: a cohort study BMJ open 15(2):e092627 2025 [PMID: 39909515]
  132. Rao A, Sabri N, Guo S, Raschid L, Lerman K. Public Health Messaging on Twitter During the COVID-19 Pandemic: Observational Study Journal of medical Internet research 27:e63910 2025 [PMID: 39908546]
  133. Regan AK, Rowe SL, Sullivan SG, Coates MM, Muñoz FM, Arah OA. Coronavirus Disease 2019 Antiviral Medication Use Among Pregnant and Recently Pregnant US Outpatients Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2025 [PMID: 39907453]
  134. Apiwattanakul M, Ounmuang C, Aungsumart S. Impact of COVID-19 and vaccination on multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) Multiple sclerosis and related disorders 95:106316 2025 [PMID: 39954490]
  135. Pupillo E, Bianchi E, Beghi E, Pedrazzini FA, Giglio A, Schilke ED, Percetti M, Colleoni CM, Mainini G, Calabresi P, Primiano G, Frisullo G, Padovani A, Cristillo V, Pilotto A, Arici D, Gipponi S, Tedeschi G, d'Ambrosio A, Melisi RD, Gallo A, Bisecco A, Salmaggi A, Basilico P, Scaccabarozzi C, Kiferle L, Valenti R, Avino G, Borghi A, Contardi S, Zini A, Ferrarese C, Beretta S. Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX) Scientific reports 15(1):4179 2025 [PMID: 39905221]
  136. Xaba N, Qureshi O, Pasha A, Malik A, Hoppe A, Tun ZM, Fynn N, Sibeko G, Khowaja S, Khan AJ. Sociodemographic and Psychosocial Factors Influencing Coronavirus Disease 2019 Testing Uptake: Insights from Urban and Rural Communities in South Africa The American journal of tropical medicine and hygiene 2025 [PMID: 39903929]
  137. Ramamonjiharisoa MBM, Liu S. Biological Significance and Therapeutic Promise of Programmed Ribosomal Frameshifting International journal of molecular sciences 26(3) 2025 [PMID: 39941062]
  138. Ternovski J, Jilke S, Keppeler F, Vogel D. Financial Incentives for COVID-19 Vaccination: A Cluster Randomized Clinical Trial JAMA network open 8(2):e2458542 2025 [PMID: 39918821]
  139. Prediger KM, Ribeiro AC, Uehara SCDSA. Prevalent symptoms and characteristics of the Long COVID-19 population: a scoping review Revista latino-americana de enfermagem 33:e4479 2025 [PMID: 39907353]
  140. Sausukpaiboon K, Penboon N, Rianthavorn P. COVID-19 vaccine hesitancy among parents of children with systemic lupus erythematosus Clinical and experimental pediatrics 2025 [PMID: 39901720]
  141. Ojo TO, Adetunji TA, Eneh SC, Akanji BO, Fajobi O, Elugbaju O, Ibigbami OI, Owojuyigbe TO, Olowookere SA, Afolabi OT, Onayade AA. COVID-19-related stress, anxiety and vaccine hesitancy among healthcare workers in a tertiary hospital in South-Western Nigeria Scientific reports 15(1):4112 2025 [PMID: 39900575]
  142. Maehara S, Kumamoto M, Nakajima S, Hieda Y, Watashi K, Hata T. Potent SARS-CoV-2 3C-like protease inhibitor ( +)-eupenoxide-3,6-diketone (IC(50): 0.048 μM) was synthesized based on ( +)-eupenoxide; lead from ( +)-eupenoxide analogs study by endophytic fermentation Journal of natural medicines 2025 [PMID: 39899217]
  143. Joo HA, Kang BC, Kim TS, Kang WS, Park HJ, Chung JW, Ahn JH. A trend of otologic diseases during the coronavirus disease 2019 pandemic period Acta oto-laryngologica :1-6 2025 [PMID: 39898862]
  144. Yang GJ, Lu M, Chen RR, Wang SQ, Wan S, Song XD, Cao GP, Lv L, He XJ, Zhan BD, Ma MJ. Neutralizing antibody responses to three XBB protein vaccines in older adults Signal transduction and targeted therapy 10(1):48 2025 [PMID: 39894858]
  145. Benavente P, Kampalath VN, Zan ML, Tran NT, Czapka EA, Hosseinalipour SM, Teran E, Martens C, Karmacharya BM, Joshi A, Das JK, Padhani ZA, Jurlano VB, Kabamalan MMM, Nyirazinyoye L, Blanchet K. Deployment and uptake of COVID-19 vaccines for refugees and migrants in regular and irregular situations: a mixed-method multicountry study BMJ open 15(1):e087629 2025 [PMID: 39894519]
  146. Li Y, Lu J, He L, Jiang C, Bao Y, Ji P, Xu J, Chen Y, Wang Y. Repeated Omicron Infections Overcome T Cell Immune Imprinting to Original SARS-CoV-2 Journal of medical virology 97(2):e70264 2025 [PMID: 39977483]
  147. Zhao Y, He C, Peng M, Li M, Liu X, Han X, Fu Q, Wu Y, Yue F, Yan C, Zhao G, Shen C. Large-Scale Screening of CD4(+) T-Cell Epitopes From SARS-CoV-2 Proteins and the Universal Detection of SARS-CoV-2 Specific T Cells for Northeast Asian Population Journal of medical virology 97(2):e70241 2025 [PMID: 39977358]
  148. Hota M, Wondeu ALD, Abakar MF, Dezoumbe K, Abdelrazakh F, Atturo S, Naïbeï N, Cappelli G, Mennechet F, Yandai FH, Abdallah DH, Edgard ZRF, Boukar A, Moussa CA, Yaya IM, Hamad MI, Armand N, Honorine N, Frederic K, Moustapha AA, Daniel YM, Alim AM, Grene M, Djarma O, Suitombaye NY, Akouya A, Choua O, Dzomo GRT, Djimtoïbaye D, Colizzi V, Moussa MA, Giovanetti M. Integrated Seroprevalence and Genome-Based Study of SARS-CoV-2 Viral Strains in N'Djamena: Insights Into Chad's COVID-19 Epicenter Journal of medical virology 97(2):e70234 2025 [PMID: 39967351]
  149. Lee DI, Nande A, Anderson TL, Levy MZ, Hill AL. Vaccine failure mode determines population-level impact of vaccination campaigns during epidemics Journal of the Royal Society, Interface 22(223):20240689 2025 [PMID: 39965640]
  150. Gentile A, Juárez MDV, Ensinck G, Lopez O, Melonari P, Fernández T, Gioiosa A, Lazarte G, Lobertti S, Lucion MF, Pejito N, Racana C, López L, Gregorio G. Comparative Analysis of Influenza Epidemiology Before and After the COVID-19 Pandemic in Argentina (2018-2019 vs. 2022-2023) Influenza and other respiratory viruses 19(2):e70078 2025 [PMID: 39962921]
  151. Barstow C, Flanagan R. Heart Disease in Children: Inflammatory Syndromes FP essentials 549:24-28 2025 [PMID: 39960778]
  152. Kuntz JL, Babu TM, Feldstein LR, Englund JA, Frivold CJ, Groom HC, Smith N, Varga AM, Cox SN, Fortmann SP, Mularski RA, Schmidt MA, Weil AA, Boisvert CL, Hollcroft M, Hatchie TL, Lo N, MacMillan MP, Reich S, Yetz N, Chu HY, Naleway AL. Knowledge About Respiratory Syncytial Virus and Acceptance of Infant Monoclonal Antibody for RSV and RSV Vaccination During Pregnancy The Pediatric infectious disease journal 44(2S):S162-S166 2025 [PMID: 39951097]
  153. De Brabandere L, Hanning N, Hendrickx G, Van Damme P, Maertens K. Vaccine Confidence During Pregnancy and the Impact of the COVID-19 Pandemic: A Wide Variety of Views Across the European Union The Pediatric infectious disease journal 44(2S):S141-S145 2025 [PMID: 39951092]
  154. Berrueta M, Ciapponi A, Bardach A, Ballivan J, Brizuela M, Castellana N, Comande D, Mazzoni A, Parker EPK, Sambade JM, Kampmann B, Stegelmann K, Xiong X, Stergachis A, Munoz FM, Buekens P. Safe in Pregnancy and Safe in Children: Global Living Systematic Reviews and Meta-analyses Hub for Emergency Vaccines The Pediatric infectious disease journal 44(2S):S111-S113 2025 [PMID: 39951087]
  155. Sturrock S, Davies H, Rukundo G, Komugisha C, Kipyeko S, Nakabembe E, Mboizi R, Sekikubo M, Le Doare K. Sociodemographic Factors Associated With Established and Novel Antenatal Vaccination Uptake in a Cohort of Pregnant Women in Uganda The Pediatric infectious disease journal 44(2S):S92-S96 2025 [PMID: 39951082]
  156. Kung S, Pike M, Eckert LO, Cheu LA, Paluvayi S, McCartney SA, Englund JA, Kachikis AB. Comparative Analysis of Transplacental SARS-CoV-2 Antibody Transfer in Pregnancy Phenotypes With Pre-eclampsia and/or Small-for-gestational-age Infants The Pediatric infectious disease journal 44(2S):S43-S45 2025 [PMID: 39951073]
  157. Deese J, Schaible K, Massierer D, Tingir N, Fell DB, Atwell JE. Systematic Literature Review of Maternal Antibodies in Human Milk Following Vaccination During Pregnancy or Lactation: Tetanus, Pertussis, Influenza and COVID-19 The Pediatric infectious disease journal 44(2S):S38-S42 2025 [PMID: 39951072]
  158. Sturrock S, Cavell B, Alexander F, Apostolakis K, Barro C, Daniel O, Dixon L, Halkerston R, Hall T, Hesp JR, Hill AM, Leung S, Lim S, McStraw N, Otter A, Ramkhelawon L, Watts R, Etti M, T Heath P, Lee-Wo C, Greening V, Khalil A, Turner K, Taylor S, Le Doare K, Ladhani S. Maternal and Placental Antibody Responses in SARS-CoV-2 Vaccination and Natural Infection During Pregnancy The Pediatric infectious disease journal 44(2S):S32-S37 2025 [PMID: 39951071]
  159. Ballivian J, Parker EPK, Berrueta M, Ciapponi A, Argento F, Bardach A, Brizuela M, Castellana N, Comande D, Kampmann B, Mazzoni A, Sambade JM, Stegelmann K, Xiong X, Munoz FM, Stergachis A, Buekens P. Immunogenicity of COVID-19 Vaccines During Pregnancy: A Systematic Review and Comparison of Pregnant Versus Nonpregnant Persons The Pediatric infectious disease journal 44(2S):S27-S31 2025 [PMID: 39951070]
  160. Gentile A, Juárez MDV, Lucion MF, Ensinck G, Lopez O, Melonari P, Fernández T, Logiosa A, Lazarte G, Lobertti S, Pejito N, Racana C, López L, Gregorio G. Respiratory Syncytial Virus Epidemiology in Argentina: From COVID-19 Pandemic to the Maternal Immunization Strategy The Pediatric infectious disease journal 44(2S):S23-S26 2025 [PMID: 39951069]
  161. Seppälä E, Bøås H, Dahl J, Stålcrantz J, Stecher M, Tønnessen R, Rø GØI, Kløvstad H, Paulsen TH. Registry-Based Surveillance of Severe Acute Respiratory Infections in Norway During 2021-2024 Influenza and other respiratory viruses 19(2):e70080 2025 [PMID: 39950571]
  162. Rivas C, Moore AP, Thomson A, Anand K, Lal ZZ, Wu AF, Aksoy O. Intersecting factors of disadvantage and discrimination and their effect on daily life during the coronavirus pandemic: the CICADA-ME mixed-methods study Health and social care delivery research 13(2):1-185 2025 [PMID: 39949202]
  163. Mao T, Zhang P, Jiang S, Li D, Li J, Zhang Q, Wang H, Kong X, Duan Z. Oral Ad5 Vector-Based SARS-CoV-2 Vaccine Effectively Induces Mucosal and Systemic Immune Responses in BALB/c Mice Journal of medical virology 97(2):e70236 2025 [PMID: 39949193]
  164. Wang J, Zhang Y, Jia Y, Xing H, Xu F, Xia B, Lai W, Yuan Y, Li X, Shan S, Chen J, Guo W, Zhang J, Zheng A, Li J, Gong N, Liang XJ. Targeting vaccines to dendritic cells by mimicking the processing and presentation of antigens in xenotransplant rejection Nature biomedical engineering 9(2):201-214 2025 [PMID: 39948171]
  165. Antonini M, Genie MG, Attwell K, Attema AE, Ward JK, Melegaro A, Torbica A, Kelly B, Berardi C, Sequeira AR, McGregor N, Kellner A, Brammli-Greenberg S, Hinwood M, Murauskienė L, Behmane D, Balogh ZJ, Hagen TP, Paolucci F. Are we ready for the next pandemic? Public preferences and trade-offs between vaccine characteristics and societal restrictions across 21 countries Social science & medicine (1982) 366:117687 2025 [PMID: 39939032]
  166. Bergna A, Lai A, Sagradi F, Menzo S, Mancini N, Bruzzone B, Rusconi S, Marchegiani G, Clementi N, Francisci D, Vicenti I, Ronchiadin S, Mbissam HD, Della Ventura C, Lanfranchi L, Testa S, Caucci S, Acciarri C, Carioti L, Occhionero A, Novazzi F, Genoni AP, Ferrante FD, De Pace V, Ferraris M, Ogliastro M, Gabrieli A, De Paschale M, Canavesi G, Bellocchi MC, Iannetta M, Sarmati L, Ceccherini-Silberstein F, Riva A, Antinori S, Zehender G. Genomic Epidemiology of the Main SARS-CoV-2 Variants Circulating in Italy During the Omicron Era Journal of medical virology 97(2):e70215 2025 [PMID: 39936851]
  167. Zhao M, Lei L, Jiang Y, Tian Y, Huang Y, Yang M. Unveiling the Threat of Disease X: Preparing for the Next Global Pandemic Journal of medical virology 97(2):e70227 2025 [PMID: 39936837]
  168. Foroutan F, Rayner DG, Oss S, Straccia M, de Vries R, Raju S, Ahmed F, Kingdon J, Bhagra S, Tarani S, Herrera S, Bhanji R, Ross H, Pruett T, Feng S, Pereira M, Rotstein C, Guyatt G, Aleksova N. Clinical Practice Recommendations on the Effect of COVID-19 Vaccination Strategies on Outcomes in Solid Organ Transplant Recipients Clinical transplantation 39(2):e70100 2025 [PMID: 39936294]
  169. Wendland ME, Simmer-Beck ML, Scott JM, Godwin SE, Hussain A, Thompkins AS. Oral Health Care Professionals' Beliefs Regarding Vaccinations and Professional Responsibility during the COVID-19 Pandemic Journal of dental hygiene : JDH 99(1):17-31 2025 [PMID: 39929521]
  170. Farpour L, Gualtieri R, Kotalova T, Lemaître B, Ducreux J, Arm-Vernez I, Eliez S, Blanchard-Rohner G. Vaccine immunity in patients with 22q11.2 microdeletion syndrome Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 36(2):e70043 2025 [PMID: 39927887]
  171. Jones J. Suveillance Learning Module: Labgold et al. (2024), Population-based denominators matter: Bias in U.S. Virgin Islands COVID-19 vaccination coverage under changing population counts Annals of epidemiology 102:125-127 2025 [PMID: 39924283]
  172. Mukhopadhyay R, Lambisia AW, Hoang JP, Ravenhill BJ, Agoti CN, Krishna BA, Houldcroft CJ. Adenovirus-Specific T Cells in Adults Are Frequent, Cross-Reactive to Common Childhood Adenovirus Infections and Boosted by Adenovirus-Vectored Vaccines Journal of medical virology 97(2):e70222 2025 [PMID: 39921609]
  173. Caglayan ISC, Demirel G, Can CE. Associations Between COVID-19 Vaccination Status and Persistent Symptoms: A Prospective Study of Reproductive-Age Women Journal of evaluation in clinical practice 31(1):e70005 2025 [PMID: 39918012]
  174. Brandstetter Figueroa E, Frosch AEP, Burrack KS, Dileepan G, Goldsmith R, Harris M, Ikeogu N, Jibrell H, Thayalan S, Dewar RL, Shenoy C, Sereti I, Baker JV. Viral Burden and Illness Severity During Acute SARS-CoV-2 Infection Predict Persistent Long COVID Symptoms Open forum infectious diseases 12(2):ofaf048 2025 [PMID: 39917335]
  175. Waghela P, Davis R, Campbell M, Datta R, Hislop MS, Vega NJ, Wurst L, Yolda-Carr D, Couch L, Hernandez M, Grant LR, Alexander-Parrish R, Arguedas A, Gessner BD, Martinello RA, Weinberger DM, Wyllie AL. Detection of Pneumococcal Carriage in Asymptomatic Healthcare Workers Open forum infectious diseases 12(2):ofaf008 2025 [PMID: 39917332]
  176. Blanchard T, Hoummady S, Rouch-Buck P, Priymenko N. Prevalence and factors associated with overweight and obesity in cats in veterinary hospitals in France during the COVID-19 pandemic Journal of feline medicine and surgery 27(2):1098612X241305924 2025 [PMID: 39916303]
  177. Coelho GM, Geremias Dos Santos H, Cataneo AHD, Zancanaro Y, Lunardelli G, Cesca TE, Makiyama J, Francisco JAFC, Skare T, Tuon FF, Zanluca C, Telles JP, Duarte Dos Santos CN. A Decrease of Antibodies Against SARS-CoV-2 Antigens Does Not Reflect a Decrease of Neutralization Rate: A Prospective Study to Evaluate Kinetic and Dynamic Humoral Immune Response After Vaccination During Pregnancy American journal of reproductive immunology (New York, N.Y. : 1989) 93(2):e70053 2025 [PMID: 39912624]
  178. Gabellone V, Nuccetelli F, Gabrielli E, Ascatigno L, Lopalco PL, Prato R. The World Café as a Tool for Evaluating the Level of Acceptance of SARS-CoV-2 Screening in School Settings, Puglia Region, Italy, 2023 Health expectations : an international journal of public participation in health care and health policy 28(1):e70137 2025 [PMID: 39905740]
  179. Öztürk F, Emiroğlu C, Aypak C. The Relationship Between Long Covid Symptoms and Vaccination Status in COVID-19 Survivors Journal of evaluation in clinical practice 31(1):e70004 2025 [PMID: 39901596]
  180. Li Z, Li J, Liu L, Chen J, Mao X, Yang J, Yang S, Li H, Li S, Meng Q. A Case Report of Anti-GD3 Antibody Positive Incomplete Miller-Fisher Syndrome With Pyramidal Tract Symptoms Clinical case reports 13(2):e70144 2025 [PMID: 39895850]
  181. Zhang S, Huang Y, Wang G, Zhang X, Xia L, Cao Y, Mou C, Chen Z, Bao W. Capsaicin inhibits porcine enteric coronaviruses replication through blocking TRPV4-mediated calcium ion influx International journal of biological macromolecules 302:140495 2025 [PMID: 39894121]
  182. Hembre BSH, Chokshi M, Hoffman SJ, Suleman F, Andresen S, Sandberg K, Røttingen JA. States, global power and access to medicines: a comparative case study of China, India and the United States, 2000-2019 Globalization and health 21(1):3 2025 [PMID: 39893431]
  183. Aghabarary M, Khedmatizare M, Norouzinia R. Perspectives of medical sciences students regarding COVID-19 vaccination: a cross-sectional study BMC health services research 25(1):191 2025 [PMID: 39893384]
  184. Shalaby A, Lachâtre M, Charlier C. [Pneumonia and pregnancy] Revue des maladies respiratoires 42(2):104-116 2025 [PMID: 39893062]
  185. Chang S, Shin J, Park S, Park H, Kim JH, Kim TW, Jung IK, Song B, Shin KS, Park B, Kim SY, Jeon JH, Yeo J, Lee TY, Kang CY. Continuous Tracking for Effective Tackling: Ad5/35 Platform-Based JN1 Lineage Vaccines Development in Response to Evolving SARS-CoV-2 Variants Journal of medical virology 97(2):e70206 2025 [PMID: 39891605]
  186. Nissilä E, Starck L, Aho E, Venerandi E, Jalkanen P, Leskinen K, Uvarov P, Saavalainen P, Julkunen I, Kotimaa J, Haapasalo K, Meri S. The COVID-19 vaccine ChAdOx1 is opsonized by anti-vector antibodies that activate complement and promote viral vector phagocytosis Scandinavian journal of immunology 101(2):e70000 2025 [PMID: 39891027]
  187. Thygesen JH, Zhang H, Issa H, Wu J, Hama T, Phiho-Gomes AC, Groza T, Khalid S, Lumbers TR, Hocaoglu M, Khunti K, Priedon R, Banerjee A, Pontikos N, Tomlinson C, Torralbo A, Taylor P, Sudlow C, Denaxas S, Hemingway H, Wu H. Prevalence and demographics of 331 rare diseases and associated COVID-19-related mortality among 58 million individuals: a nationwide retrospective observational study The Lancet. Digital health 7(2):e145-e156 2025 [PMID: 39890245]
  188. Husin M, Tok PSK, Suah JL, Tng BH, Thevananthan T, Peariasamy KM, Sivasampu S. Effectiveness of homologous and heterologous BNT162b2 and CoronaVac booster vaccination against severe COVID-19 outcomes Journal of infection in developing countries 19(1):9-12 2025 [PMID: 39977462]
  189. Liu J, Hu G, Liu S, Ren G, Gao L, Zhao Z, Geng R, Wang D, Shen X, Chen F, Shen H. Evaluating passive immunity in piglets from sows vaccinated with a PEDV S protein subunit vaccine Frontiers in cellular and infection microbiology 14:1498610 2024 [PMID: 39963235]
  190. Yu C, Wang W, Zhang Q, Jin Z. Autoimmune hepatitis under the COVID-19 veil: an analysis of the nature of potential associations Frontiers in immunology 16:1510770 2025 [PMID: 39958350]
  191. Maison DP, Tasissa H, Deitchman A, Peluso MJ, Deng Y, Miller FD, Henrich TJ, Gerschenson M. COVID-19 clinical presentation, management, and epidemiology: a concise compendium Frontiers in public health 13:1498445 2025 [PMID: 39957982]
  192. Alhamlan FS, Al-Qahtani AA. SARS-CoV-2 Variants: Genetic Insights, Epidemiological Tracking, and Implications for Vaccine Strategies International journal of molecular sciences 26(3) 2025 [PMID: 39941026]
  193. Izadiyan Z, Misran M, Kalantari K, Webster TJ, Kia P, Basrowi NA, Rasouli E, Shameli K. Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine International journal of nanomedicine 20:1213-1262 2025 [PMID: 39911259]
  194. Araújo FC, Amaral ACD, Silva HJ, Santos JNV, Mendonça VA, Oliveira VC, Rocha-Vieira E. Autoantibodies as potential prognostic factors for clinical outcomes related to COVID-19: a systematic review of inception prospective cohort studies with GRADE recommendations Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 58:e13965 2025 [PMID: 39907423]
  195. Jin Z, Liu J, Guo S, Xu S, Gong X, Zhang C, Zhao K. N-2-Hydroxypropyl Trimethyl Ammonium Chloride Chitosan-Aluminum Nano-Adjuvant Elicit Strong Immune Responses in Porcine Epidemic Diarrhea Inactivated Vaccine International journal of nanomedicine 20:1321-1334 2025 [PMID: 39906524]
  196. Quint JK, Dube S, Carty L, Yokota R, Bell S, Turtle L, Lu Y, Evans K, Justo N, Harley M, Peters J, Talarico C, McNulty R, Goios A, Taylor S, Evans RA. Immunocompromised individuals remain at risk of COVID-19: 2023 results from the observational INFORM study The Journal of infection 90(3):106432 2025 [PMID: 39894447]
  197. Itamochi M, Yazawa S, Saga Y, Shimada T, Fukuyama K, Oishi K, Tani H. A transient reduction of the varicella-zoster virus-specific immunoglobulin G level after vaccination against severe acute respiratory syndrome coronavirus 2 with an mRNA vaccine in nursing home residents, but not staff Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 31(4):102637 2025 [PMID: 39892508]
  198. Golpour M, Jalali H, Alizadeh-Navaei R, Talarposhti MR, Mousavi T, Ghara AAN. Co-infection of SARS-CoV-2 and influenza A/B among patients with COVID-19: a systematic review and meta-analysis BMC infectious diseases 25(1):145 2025 [PMID: 39891054]
  199. Ni J, Zheng Y, Tian J, Zhang L, Duan S. Risk of neonatal SARS-CoV-2 infection: a retrospective cohort study based on infected mothers with gestational diabetes mellitus Frontiers in endocrinology 16:1483962 2025 [PMID: 39950026]
  200. Wiegand RE, Devine O, Wallace M, Ortega-Sanchez IR, Pham HT, Khan D, Moulia DL, Roper LE, Trejo I, Fleming-Dutra KE, Havers FP, Taylor CA. Estimating COVID-19 associated hospitalizations, ICU admissions, and in-hospital deaths averted in the United States by 2023-2024 COVID-19 vaccination: A conditional probability, causal inference, and multiplier-based approach Vaccine 49:126808 2025 [PMID: 39889531]
  201. Willis LD, Spray BJ, Henderson E, Lloyd T, Irby K, Sanders R Jr. Characteristics and Outcomes of Children Hospitalized With COVID-19 During Early Pandemic and Delta Variant Respiratory care 2025 [PMID: 39969916]
  202. Azoicai AN, Miron I, Lupu A, Alexoae MM, Starcea IM, Alecsa M, Lupu VV, Danielescu C, Nedelcu AH, Salaru DL, Dragan F, Ioniuc I. COVID-19 vaccination: challenges in the pediatric population Frontiers in public health 12:1390951 2024 [PMID: 39944570]
  203. Handayani EW, Perwitasari DA, Purba FD. Health belief model of parents' COVID-19 vaccination intentions for children: perceived benefits and barriers in Indonesia Frontiers in public health 12:1485416 2024 [PMID: 39944569]
  204. Kwella H, Schilbert J, Tessartz A, Scheersoi A. From classrooms to real-world contexts: enhancing vaccine education through open schooling Frontiers in public health 13:1520395 2025 [PMID: 39944073]
  205. Shabani M, Nejati A, Yavarian J, Sadeghi K, Zadheidar S, Ahmadi AS, Ghadirali M, Zebardast A, Abedi A, Najmi MH, Shafiei-Jandaghi NZ, Mokhtari-Azad T. The trend of phylogenetic and epitope variations of SARS-CoV-2 Omicron sub-lineages in Iran Frontiers in microbiology 15:1531712 2024 [PMID: 39943963]
  206. Li L, Zhang X, Yan H, Dai M, Gao H, Wang Y, Jiang P, Dai E. Different immunological characteristics of asymptomatic and symptomatic COVID-19 patients without vaccination in the acute and convalescence stages PeerJ 13:e18451 2025 [PMID: 39897496]
  207. Montagud AC, Moragues R, Vicente-Alcalde N, Montagud E, Hurtado-Sánchez JA, Tuells J. Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain) Frontiers in public health 13:1490809 2025 [PMID: 39935883]
  208. Chen Z, Xie F, Zhang H, Li D, Zhang S, Zhang M, Li J, Xie J, Zhang L, Yang X, Zhang D. Waning neutralizing antibodies through 180 days after homologous and heterologous boosters of inactivated COVID-19 vaccine Frontiers in public health 13:1478627 2025 [PMID: 39935878]
  209. Xagoraraki I, Zhao L, Li Y, Miyani B, Norton J, Broz J, Kaye A, Mehrotra A, Gosine A, Withington S, McFarlane S, Faust RA. Community case study: an academia-industry-government partnership that monitors and predicts outbreaks in Tri-County Detroit area since 2017 Frontiers in public health 12:1475425 2024 [PMID: 39935746]
  210. Gattinger P, Kozlovskaya LI, Lunin AS, Gancharova OS, Sirazova DI, Apolokhov VD, Chekina ES, Gordeychuk IV, Karaulov AV, Valenta R, Ishmukhametov AA. Fusion protein-based COVID-19 vaccines exemplified by a chimeric vaccine based on a single fusion protein (W-PreS-O) Frontiers in immunology 16:1452814 2025 [PMID: 39935478]
  211. Takeshita T, Nishimiya N, Hihara Y. Does COVID-19 infection or COVID-19 mRNA vaccination induce antiphospholipid antibodies in women with recurrent pregnancy loss? Journal of reproductive immunology 168:104442 2025 [PMID: 39893808]
  212. Kwon E, Blank G, Starkey S, Chapman C, Lategan C, Shulha H, Kitchin V, Silverberg S, Sauvé L, Sadarangani M. Child Transmission of SARS-CoV-2 Throughout the Pandemic: An Updated Systematic Review and Meta-Analysis The Pediatric infectious disease journal 2025 [PMID: 39889734]
  213. Hickey TE, Mudunuri U, Hempel HA, Kemp TJ, Roche NV, Talsania K, Sellers BA, Cherry JM, Pinto LA. Proteomic and serologic assessments of responses to mRNA-1273 and BNT162b2 vaccines in human recipient sera Frontiers in immunology 15:1502458 2024 [PMID: 39931577]
  214. Öztürk GZ, Demir İ, Yılmaz ZU. Effects of COVID-19 and pneumococcal conjugate vaccines on hospitalized older COVID-19 patients in Türkiye Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 31(1):24-29 2025 [PMID: 39945182]
  215. Benkaddour NEH, Ramdani S, Khalil H, Lekfif A, Abda N, Oneib B, Bentata Y. Exploring healthcare workers' immunisation behaviour towards COVID-19 vaccines through psychological patterns African journal of primary health care & family medicine 17(1):e1-e11 2025 [PMID: 39935121]
  216. Du H, Li J, Wen H, Gu Z, Chang Y, Rong W, Yang Z, Khan RU, Feng Z, Wang Q, Song R, Bi Y. Respiratory Pathogen Profiles of Patients - Beijing Municipality, China, November 2023-April 2024 China CDC weekly 7(4):113-120 2025 [PMID: 39931441]
  217. Li S, Noroozizadeh S, Moayedpour S, Kogler-Anele L, Xue Z, Zheng D, Montoya FU, Agarwal V, Bar-Joseph Z, Jager S. mRNA-LM: full-length integrated SLM for mRNA analysis Nucleic acids research 53(3) 2025 [PMID: 39898548]
  218. Herrera BB, Chaplin B, MBoup S, Abdullahi A, He M, Fisher SM, Akanmu S, Chang CA, Hamel DJ, Gupta RK, Kanki PJ. Pre-pandemic cross-reactive antibody and cellular responses against SARS-CoV-2 among female sex workers in Dakar, Senegal Frontiers in public health 13:1522733 2025 [PMID: 39916712]
  219. Tandel K, Niveditha D, Singh SP, Anand KB, Shinde V, Ghedia M, Sondakar A, Reddy M. Decoding omicron: Genetic insight into its transmission dynamics, severity spectrum and ever-evolving strategies of immune escape in comparison with other SARS-CoV-2 variants Diagnostic microbiology and infectious disease 111(3):116705 2025 [PMID: 39889436]
  220. Dandotiya J, Adhikari N, Tripathy MR, Jakhar K, Sonar S, Pati DR, Kanchan V, Prasad VS, Kumar J, Senapati NK, Bharmoria A, Rani N, Lakhanpal M, Patil CS, Singh N, Khan L, Jambu L, Jain NK, Ali SK, Priyadarsiny P, Panda AK, Jain R, Mani S, Samal S, Awasthi A, Rizvi ZA. CoviWall, a whole-virion-inactivated B.1.617.2 vaccine candidate, induces potent humoral and Th1 cell response in mice and protects against B.1.617.2 strain challenge in Syrian hamsters Frontiers in immunology 15:1447962 2024 [PMID: 39911577]
  221. Taube M, Lesiņa AA. Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series Frontiers in psychiatry 15:1514428 2024 [PMID: 39911555]
  222. Awadalla M, AlRawi HZ, Henawi RA, Barnawi F, Alkadi H, Alyami A, Alsughayir A, Alsaif AS, Mubarak A, Alturaiki W, Alosaimi B. Humoral and cellular immune durability of different COVID-19 vaccine platforms following homologous/heterologous boosters: one-year post vaccination Frontiers in immunology 16:1526444 2025 [PMID: 39911379]
  223. Unninayar D, Falcone EL, Chapdelaine H, Vinh DC, Top KA, Derfalvi B, Issekutz TB, Decaluwe H, Pham-Huy A, Upton J, Betschel SD, Rubin T, Suresh S, Wright NAM, Murguía-Favela L, Kalashnikova T, Barrett L, Oldford S, Langlois MA, Arnold C, Sadarangani M, Zhang T, Ramsay T, Yazji D, Cowan J. Humoral and cell-mediated immune responses to COVID-19 vaccines up to 6 months post three-dose primary series in adults with inborn errors of immunity and their breakthrough infections Frontiers in immunology 15:1501908 2024 [PMID: 39906736]
  224. Foláyan MO, Dubé K, Ndembi N. Standard of prevention for infectious diseases' prevention clinical trials during pandemics: learning lessons for global policies from biomedical HIV prevention clinical trials and a case study of COVID-19 Frontiers in public health 12:1539840 2024 [PMID: 39906399]
  225. Douthitt W, Murray JH, Stahlman SL. Ovarian dysfunction and polycystic ovary syndrome in the U.S. military active component, 2014-2023 MSMR 32(1):11-17 2025 [PMID: 39965137]
  226. Lamure S, Chavez HH, de Goër de Herve MG, Fornecker LM, Drenou B, Jacquet C, Merabet F, Kohn M, Quélin F, Jackson A, Choquet S, Duléry R, Taoufik Y, Besson C. Lymphoma patients treated with anti-CD20 and chemotherapy display disconnected T and B cell responses to COVID-19 vaccine Frontiers in immunology 15:1524813 2024 [PMID: 39902042]
  227. Silubonde TM, Draper CE, Norris SA. A survey of perceptions and behavioural responses towards the COVID-19 pandemic in South Africa African journal of primary health care & family medicine 17(1):e1-e8 2025 [PMID: 39935119]
  228. Chittajallu LVS, Kaku R, Kondadasula P, Lim JY, Zhumabekova A. Safety and Efficacy of Vaccines During Pregnancy: A Systematic Review Cureus 17(1):e77176 2025 [PMID: 39925513]
  229. Litins'ka Y. Breaking vaccination barriers among migrants? Human rights and crisis preparedness Medical law review 33(1) 2025 [PMID: 39919285]
  230. Alshahrani MS, Aldahhan R, Macadato NC, Alkhalifah Z, Tahan MRE, Alnimr A, Alnabi MA, Almishkab F, Almusairii J, Asonto LP, Almusawi SM, Almussalam M, Alsanea R, Albakheet MK, Albrahim TA, Alammar MS, Albehair M, Alkhater SA, Alsulaibikh A, Aljumaan M, AlQahtani SM, Abdelhady A, Mapusao C, Attia A, Alzamil IA. Binding Antibodies Responses to SARS-COV-2 Infection in Hospitalized Patients and Vaccinated Subjects: A Longitudinal Prospective Observational Study Saudi journal of medicine & medical sciences 13(1):39-46 2025 [PMID: 39936001]
  231. Shamshirgaran A, Taheri D, Yahyazadeh SR, Baghdadabad LZ, Zahmatkesh P, Yar EZ, Alaeddini F, Khoshchehreh M, Mohammadi A, Tavoosian A, Aghamir SMK. Impact of COVID-19 vaccination on lower urinary tract (LUTS) in benign prostatic hyperplasia (BPH) patients Clinical and experimental vaccine research 14(1):44-50 2025 [PMID: 39927226]
  232. Nakano H, Nakashima S, Imai Y, Uchida T, Inoue M, Hagihara M. [Prophylactic efficacy of tixagevimab/cilgavimab in patients with hematological neoplasms: a single-center study] [Rinsho ketsueki] The Japanese journal of clinical hematology 66(1):3-6 2025 [PMID: 39924204]
  233. Sari N, Bacı B, Canlı MS, Çınar O, Durgut SU, Olcar Z, Sel Ç, Yıldırım E, Karakaya E, Kurt Azap Ö, Sezgin A, Haberal M. Unveiling the Viral Challenges: A 5-Year Review of Infections in Solid-Organ Transplant Patients Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 23(1):60-66 2025 [PMID: 39918194]
  234. Szarzanowicz AM, Fabian K, Alexandri M, Robinson CA, Singh S, Wallace M, Penque MD, Nan N, Ma C, Reynolds BZ, Harvey BW, Suffoletto H, Brooke Lerner E. Self-Reported COVID-19 Vaccine Status and Barriers for Pediatric Emergency Patients and Caregivers The western journal of emergency medicine 26(1):96-9102 2025 [PMID: 39918148]
  235. Mirza AA, Almalki AH, Noori FA, Neazy SA, Dahm V, Bajin MD, Lin VY. Facial Nerve Palsy Amid the SARS-CoV-2 Pandemic: A Pooled Analysis Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale 54:19160216251315057 2025 [PMID: 39916377]
  236. Jones J, Barnhill A, Esmonde K, Hutler B, Johns M, Faden R. Views From State-Level Policy Actors About the US Federal Government COVID-19 Response Health security 23(1):1-8 2025 [PMID: 39905974]
  237. Meijers M, Ruchnewitz D, Eberhardt J, Karmakar M, Łuksza M, Lässig M. Concepts and Methods for Predicting Viral Evolution Methods in molecular biology (Clifton, N.J.) 2890:253-290 2025 [PMID: 39890732]
  238. Gushansky KY, Tuuminen R. Exploring the protective effects of vasoactive intestinal peptides on dry eye disease in SARS-CoV-2 survivors Molecular vision 30:489-496 2024 [PMID: 39959180]
  239. Konieczny M, Sobieraj D, Niezgoda A, Gąska I, Mielnik A, Niemiec M, Cipora E. Attitudes of pregnant women toward vaccination against COVID-19 - a study conducted in Poland in the first quarter of 2022 Central European journal of public health 32(4):225-230 2024 [PMID: 39903591]
  240. Rhodes P, Parry PI. Pharmaceutical product recall and educated hesitancy towards new drugs and novel vaccines The International journal of risk & safety in medicine 35(4):317-333 2024 [PMID: 39973420]
  241. Tarahomi M, Shokri Koohikheyli MS, Pooya P, Eslami M, Vakili M, Habibian F, Naderian R, Zolfaghari M, Ghaffari H. The Prevalence and Clinical Features of Co-Infection with SARS-CoV-2 and Influenza Virus during the COVID-19 Pandemic in Semnan, Iran Medical journal of the Islamic Republic of Iran 38:101 2024 [PMID: 39968478]
  242. Kostić A, Ilić J, Stojanović N, Janković R, Nikolov V, Živković S. ELEVATED SERUM C-REACTIVE PROTEIN LEVELS IN COVID-19 PATIENTS WITH SCIATICA: IMPLICATIONS FOR PROGNOSIS AND TREATMENT STRATEGIES Acta clinica Croatica 63(1):149-156 2024 [PMID: 39959316]
  243. Boggess B, Thomas H, Ruiz J, Mandujano-Acevedo N, Rodriguez-Lainz A. Covid-19 disease burden, vaccine uptake, and workplace disease prevention efforts in temporary agricultural workers in the US Salud publica de Mexico 66(2, mar-abr):119-129 2024 [PMID: 39977040]

Ebola virus

  1. G Gürtler L, Schramm W, Seitz R. Viral sepsis - pathophysiology and disease manifestation Infection 2025 [PMID: 39961996]
  2. Jamal QMS, Ansari MA, Alharbi AH, Alomary MN, Jamous YF, Dutta T, Maity A, Ahmad V. Computational study of interaction of calixarene with ebola virus structural proteins and its potential therapeutic implications Journal of molecular graphics & modelling 136:108976 2025 [PMID: 39961277]
  3. Ingabire R, Nyombayire J, Mazzei A, Mazarati JB, Noben J, Katwere M, Parker R, Nsanzimana S, Wall KM, Sharkey T, Sayinzoga F, Tichacek A, Hammoud N, Martinson E, Magod B, Allen S, Karita E. Contraception use and pregnancy in women receiving a 2-dose Ebola vaccine in Rwanda: A retrospective analysis of UMURINZI vaccination campaign data PLoS medicine 22(2):e1004508 2025 [PMID: 39932900]
  4. Devaraj AR, Marianthiran VJ. Advancements in Viral Genomics: Gated Recurrent Unit Modeling of SARS-CoV-2, SARS, MERS, and Ebola viruses Revista da Sociedade Brasileira de Medicina Tropical 58:e004012024 2025 [PMID: 39936709]
  5. Sun FY, Liu W, Ding SJ, Yan FR, Wang J, Peng ZH. [Innovative design and statistical considerations in vaccine clinical trials] Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 59(2):254-259 2025 [PMID: 39939000]
  6. Jenkin D, Makinson R, Sanders H, Sampson A, Platt A, Tran N, Dinesh T, Mabbett R, Lawrie A, Quaddy J, Poulton I, Berrie E, Cicconi P, Lambe T. Safety and immunogenicity of a bivalent Ebola virus and Sudan virus ChAdOx1 vectored vaccine in adults in the UK: an open-label, non-randomised, first-in-human, phase 1 clinical trial The Lancet. Microbe :101022 2025 [PMID: 39922207]
  7. Hastie KM, Salie ZL, Ke Z, Halfmann PJ, DeWald LE, McArdle S, Grinyó A, Davidson E, Schendel SL, Hariharan C, Norris MJ, Yu X, Chennareddy C, Xiong X, Heinrich M, Holbrook MR, Doranz B, Crozier I, Kawaoka Y, Branco LM, Kuhn JH, Briggs JAG, Worwa G, Davis CW, Ahmed R, Saphire EO. Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP((1,2)) in a position elevated from the virion membrane Nature communications 16(1):1293 2025 [PMID: 39900911]
  8. Bu F, Ye G, Turner-Hubbard H, Herbst M, Liu B, Li F. Cryo-EM structure of Sudan ebolavirus glycoprotein complexed with its human endosomal receptor NPC1 Communications biology 8(1):156 2025 [PMID: 39894818]
  9. Waitt C, Gribble K, Waitt P, Imani-Musimwa P, Liang C, Ververs M. Scarcity of research on breastfeeding and Ebola diseases is placing the lives of women and infants at risk: a call to specific action The Lancet. Global health 13(2):e364-e371 2025 [PMID: 39890236]

Escherichia coli

  1. Liu Y, Chen D, Zhao L, Zhang H, Wu S, Chen X, Shen E, Li L, Yang Z, Wang Y, Yin F, Zhang Y, Shi Y, Zhou S, Li S, Du X, Guo J, Wang D, Wang H, Liu S, Jin G, Zhang H, Yu X, Chen X, Shang L, Liu Y, Liu Y. Stability study of recombinant 9-valent human papillomavirus vaccine based on Escherichia coli expression system Human vaccines & immunotherapeutics 21(1):2455807 2025 [PMID: 39973250]
  2. Flannery DD, Ramachandran V, Schrag SJ. Neonatal Early-Onset Sepsis: Epidemiology, Microbiology, and Controversies in Practice Clinics in perinatology 52(1):15-31 2025 [PMID: 39892950]
  3. Akbulut I, Ödemiş İ, Atalay S. Analysis of local and systemic side effects of bacillus Calmette-Guérin immunotherapy in bladder cancer: a retrospective study in Türkiye PeerJ 13:e18870 2025 [PMID: 39959825]
  4. Maciel M Jr, Scott JC, Baudier RL, Clements JD, Laird RM, Gutiérrez RL, Porter CK, Norton EB. Protective antibodies against enterotoxigenic Escherichia coli are generated from heat-labile toxoid vaccination and exhibit subject- and vaccine-specific diversity Medical microbiology and immunology 214(1):10 2025 [PMID: 39934422]
  5. Liu J, Jokiranta TS, Carlin N, Stroup S, Zhang J, Sjostrand B, Svennerholm A-M, Houpt ER, Kantele A. Use of a TaqMan Array Card for identification of enterotoxins and colonization factors directly from stool samples in an enterotoxigenic E. coli vaccine study Microbiology spectrum :e0187024 2025 [PMID: 39932427]
  6. Chen M, Cui R, Hong S, Zhu W, Yang Q, Li J, Nie Z, Zhang X, Ye Y, Xue Y, Wang D, Hong Y, Drlica K, Niu J, Zhao X. Broad-spectrum tolerance to disinfectant-mediated bacterial killing due to mutation of the PheS aminoacyl tRNA synthetase Proceedings of the National Academy of Sciences of the United States of America 122(6):e2412871122 2025 [PMID: 39899725]
  7. Li HR, Zhou Y, Ye BC. Tumor-Targeted Delivery of PD-1-Displaying Bacteriophages by Escherichia coli for Adjuvant Treatment of Colorectal Cancer ACS synthetic biology 2025 [PMID: 39929739]
  8. Schmidt MA, Blum M, Donald JL, Meenan RT, Carrió E, Poolman J, Neary MP, Verstraeten T, Geurtsen J. Economic and Disease Burden Associated with Invasive Escherichia coli Disease in the United States Infectious diseases and therapy 2025 [PMID: 39921800]
  9. Neary MP, Catillon M, Ahmad N, Gauthier-Loiselle M, Geurtsen J, Qu A, Willame C, Cloutier M, El Khoury AC, Saade E. Risk of Invasive Escherichia coli (E. coli) Disease After Elective Urologic Procedures Among Older Adults in the United States Infectious diseases and therapy 2025 [PMID: 39918690]
  10. Walker RI. Conserved antigens for enteric vaccines Vaccine 50:126828 2025 [PMID: 39914256]
  11. Negri LB, Korupolu S, Farinelli W, Jolly AK, Redmond RW, Aggarwal S, Rahme LG, Gilchrist KH, Anderson RR, Gelfand JA. Antimicrobial Blue Light Reduces Human-Wound Pathogens' Resistance to Tetracycline-Class Antibiotics in Biofilms Cells 14(3) 2025 [PMID: 39937010]
  12. Peng Y, Wu J, Sun Y, Zhang Y, Wang Q, Shao S. Contrastive-learning of language embedding and biological features for cross modality encoding and effector prediction Nature communications 16(1):1299 2025 [PMID: 39900608]
  13. Campero LM, Gual I, Sander VA, Morales LFM, Duarte VAR, Formigo PM, Sosa E, Lázaro F, Scioli MV, Atela A, Legarralde A, Hozbor FA, Cantón GJ, Angel SO, Moore DP, Clemente M. Immunization with plant-based vaccine expressing Toxoplasma gondii SAG1 fused to plant HSP90 elicits protective immune response in lambs Acta tropica 262:107540 2025 [PMID: 39894243]
  14. Pasetti MF, Milletich PL, White JA, Butts J, Brady RC, Dickey MD, Ballou C, Maier N, Sztein MB, Baqar S, Louis Bourgeois A, Bernstein DI. Safety and immunogenicity in humans of enterotoxigenic Escherichia coli double mutant heat-labile toxin administered intradermally NPJ vaccines 10(1):23 2025 [PMID: 39893179]
  15. Acosta-Benites J, Jara LM, Verastegui Pimentel M, Obregón Maldonado PM, Altamirano-Zevallos F, Valencia Mamani N, Gavidia CM. Development of the antigenic recombinant tropomyosin of Echinococcus granulosus in a bacterial system as a vaccinal candidate against canine echinococcosis Revista peruana de medicina experimental y salud publica 41(4):411-416 2025 [PMID: 39936765]
  16. Guo W, Wang X, Hu J, Zhang B, Zhao L, Zhang G, Qi J, Wei Z, Bao Y, Tian M, Wang S. In silico design of a multi-epitope vaccine against Mycobacterium avium subspecies paratuberculosis Frontiers in immunology 16:1505313 2025 [PMID: 39935480]
  17. Khairullah AR, Afnani DA, Riwu KHP, Widodo A, Yanestria SM, Moses IB, Effendi MH, Ramandinianto SC, Wibowo S, Fauziah I, Kusala MKJ, Fauzia KA, Furqoni AH, Raissa R. Avian pathogenic Escherichia coli: Epidemiology, virulence and pathogenesis, diagnosis, pathophysiology, transmission, vaccination, and control Veterinary world 17(12):2747-2762 2024 [PMID: 39897356]

Hantavirus

  1. Wei J, Zhang H, Pei J, Yang Q, Wang Y, Jin X, Liu H, Zhang L, Ma H, Cheng L, Dong Y, Lei Y, Bai Y, Xu Z, Yu P, Zhang F, Ye W. Standardization, validation, and comparative evaluation of a convenient surrogate recombinant vesicular stomatitis virus plaque reduction test for quantification of Hantaan orthohantavirus (HTNV) neutralizing antibodies Virology journal 22(1):31 2025 [PMID: 39923054]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

  1. Bondy S, McClymont E, Av-Gay G, Albert A, Andrade J, Blitz S, Folkes I, Forward L, Fraser E, Grays S, Barrett J, Bettinger J, Bogler T, Boucoiran I, Castillo E, D'Souza R, El-Chaâr D, Fadel S, Kuret V, Ogilvie GS, Poliquin V, Sadarangani M, Scott H, Snelgrove JW, Tunde-Byass M, Money D. Acceptance and attitudes towards COVID-19 vaccination during pregnancy in Canada Human vaccines & immunotherapeutics 21(1):2458353 2025 [PMID: 39898697]
  2. Sandherr M, Stemler J, Schalk E, Hattenhauer T, Hentrich M, Hertenstein B, Hohmann C, Mellinghoff SC, Mispelbaum R, Rieger C, Schmidt-Hieber M, Sprute R, Weiss G, Cornely OA, Henze L, Lass-Floerl C, Beutel G, Classen AY, Freise NF, Karthaus M, Koehler P, Krause R, Neuhann J, Orth HM, Penack O, Schaich M, Spiekermann K, Voigt S, Weissinger F, Busch E. 2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies The Lancet regional health. Europe 51:101214 2025 [PMID: 39973942]
  3. Theodore DA, Neradilek M, Gillespie K, Edupuganti S, Hinojosa JC, Lama JR, De La Grecca R, Wu YH, Davis A, Mangini D, Andrew P, Marovich MA, Zwerski S, Broder G, Andrasik MP, Castor D, Roxby AC, Cohen M, Huang Y, Karuna ST, Sobieszczyk ME. Brief Report: Associations Between Gender and Solicited Adverse Events After Passive Infusion of VRC01 or Placebo in HVTN 704/HPTN 085 Journal of acquired immune deficiency syndromes (1999) 98(4):340-345 2025 [PMID: 39970314]
  4. Khairunisa SQ, Rachman BE, Nasronudin, Fahmi M, Dinana IA, Ito M. Designing a multi-epitope vaccine targeting the HIV-1 subtype CRF01_AE in Indonesia Computers in biology and medicine 187:109758 2025 [PMID: 39889449]
  5. Gopalkrishnan K, Karim R. Addressing Global Disparities in Cervical Cancer Burden: A Narrative Review of Emerging Strategies Current HIV/AIDS reports 22(1):18 2025 [PMID: 39979520]
  6. Zaslavsky ME, Craig E, Michuda JK, Sehgal N, Ram-Mohan N, Lee JY, Nguyen KD, Hoh RA, Pham TD, Röltgen K, Lam B, Parsons ES, Macwana SR, DeJager W, Drapeau EM, Roskin KM, Cunningham-Rundles C, Moody MA, Haynes BF, Goldman JD, Heath JR, Chinthrajah RS, Nadeau KC, Pinsky BA, Blish CA, Hensley SE, Jensen K, Meyer E, Balboni I, Utz PJ, Merrill JT, Guthridge JM, James JA, Yang S, Tibshirani R, Kundaje A, Boyd SD. Disease diagnostics using machine learning of B cell and T cell receptor sequences Science (New York, N.Y.) 387(6736):eadp2407 2025 [PMID: 39977494]
  7. Gispen F, Marks KM. Update on Vaccination Recommendations for Adults with HIV Current HIV/AIDS reports 22(1):17 2025 [PMID: 39976870]
  8. Reddy K, Lee GQ, Reddy N, Chikowore TJB, Baisley K, Dong KL, Walker BD, Yu XG, Lichterfeld M, Ndung'u T. Differences in HIV-1 reservoir size, landscape characteristics, and decay dynamics in acute and chronic treated HIV-1 Clade C infection eLife 13 2025 [PMID: 39976231]
  9. Zhu S, Chen D, Yang X, Yang L, Han Y. Organoid Models to Study Human Infectious Diseases Cell proliferation :e70004 2025 [PMID: 39973397]
  10. Gathe JC, Dejesus E, Ramgopal MN, Rolle CP, Yang OO, Sanchez WE, Lalezari JP, Krishen A, Sacha JB, Hansen SG, Meidling J. Leronlimab Treatment for Multidrug-Resistant HIV-1 (OPTIMIZE): a Randomized, Double-Blind, Placebo-Controlled Trial Journal of acquired immune deficiency syndromes (1999) 2025 [PMID: 39972543]
  11. Chawana TD, Walsh SR, Stranix-Chibanda L, Chirenje ZM, Yu C, Zhang L, Seaton KE, Heptinstall J, Zhang L, Paez CA, Gamble T, Karuna ST, Andrew P, Hanscom B, Sobieszczyk ME, Edupuganti S, Gay CL, Mannheimer SB, Hurt CB, Stephenson KE, Polakowski LL, Spiegel H, Yacovone M, Regenold S, Yen C, Baumblatt JA, Gama L, Barouch DH, Piwowar-Manning E, Koup RA, Tomaras GD, Hyrien O, Roxby AC, Huang Y. Pharmacokinetic interaction assessment of an HIV broadly neutralizing monoclonal antibody VRC07-523LS: a cross-protocol analysis of three phase 1 trials in people without HIV BMC immunology 26(1):8 2025 [PMID: 39966732]
  12. Makrides J, Galai N, Lopez A, Trexler C, McCree D, Matson PA, Trent M, Marcell AV, Arrington-Sanders R. Being Out: Impact of Disclosure on Sexual and Reproductive Healthcare Receipt in a Sample of Sexual Minority Women and Gender Diverse Youth The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2025 [PMID: 39969472]
  13. Bertrand L, Nelde A, Ramirez BC, Hatin I, Arbes H, François P, Demais S, Labaronne E, Decimo D, Guiguettaz L, Grégoire S, Bet A, Beauclair G, Gross A, Ziegler MC, Pereira M, Jeger-Madiot R, Verdier Y, Vinh J, Cardinaud S, Graff-Dubois S, Esclatine A, Gouttefangeas C, Altfeld M, Hocqueloux L, Samri A, Autran B, Lambotte O, Rammensee HG, Ricci EP, Walz J, Namy O, Moris A. Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling Nature communications 16(1):1707 2025 [PMID: 39966340]
  14. Chaturvedi M, Epling BP, Pei L, Sullivan B, Kuehn HS, Hammoud DA, Rosenzweig S, Pai SY, Sereti I, Freeman AF, Cuellar-Rodriguez J, Gonzalez CE, Manion M. Infection-Associated Immune Reconstitution Inflammatory Syndrome in Hematopoietic Cell Transplantation Transplant infectious disease : an official journal of the Transplantation Society :e70000 2025 [PMID: 39964133]
  15. Dutra K, Lewis A, Counts R. Sexually Transmitted Infection Considerations Following Sexual Assault Clinical obstetrics and gynecology 2025 [PMID: 39962703]
  16. White E, Kityo C, Spyer MJ, Mujuru HA, Nankya I, Kekitiinwa AR, Lugemwa A, Kaudha E, Liberty A, Cassim H, Archary M, Cotton MF, Ahimbisibwe GM, Cressey TR, Ngampiyaskul C, Srirompotong U, Behuhuma O, Saidi Y, Bamford A, Kobbe R, Nastouli E, Rojo P, Giaquinto C, Gibb DM, Ford D, Turkova A. Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial The lancet. HIV 2025 [PMID: 39978387]
  17. Cheng Z, Sun Y, Shen Y, Wu X, Pan L, Wu H, Bai Y, Zhao C, Ma J, Huang W. A Single Mutation at Position 214 of Influenza B Hemagglutinin Enhances Cross-Neutralization Emerging microbes & infections :2467770 2025 [PMID: 39960410]
  18. Akbari E, Milani A, Moradi Pordanjani P, Seyedinkhorasani M, Agi E, Bolhassani A. Immunostimulatory effects of Hsp70 fragments-modified DCs: A computational and experimental study in HIV vaccine design Microbes and infection :105480 2025 [PMID: 39956447]
  19. Hu Y, Zhang Y, Jiang W. Targeting hepatitis B virus-associated nephropathy: efficacy and challenges of current antiviral treatments Clinical and experimental medicine 25(1):57 2025 [PMID: 39954162]
  20. Ben-Akiva E, Chapman A, Mao T, Irvine DJ. Linking vaccine adjuvant mechanisms of action to function Science immunology 10(104):eado5937 2025 [PMID: 39951545]
  21. Alves E, Currenti J, Crawford K, Chopra A, Ram R, Barnett L, Read JF, Al-Kaabi M, James I, Carlson JM, Eton M, Stelmach S, Deshpande P, Pilkinton MA, McDonnell WJ, Bosco A, Mallal SA, John M, Kalams SA, Gaudieri S. HIV-1 adapts to HLA class II-associated selection pressure exerted by CD4(+) and CD8(+) T cells Science advances 11(7):eadr4238 2025 [PMID: 39951541]
  22. Apea V, Titanji BK, Dakin FH, Hayes R, Smuk M, Kawu H, Waters L, Levy I, Kuritzkes DR, Gandhi M, Rockstroh J, Schechter M, Holt M, Palich R, Cortes CP, Nozza S, Mussini C, Calmy A, Crabtree-Ramirez BE, Blanco JL, Bhagani S, Dewsnap C, Orkin C. International healthcare workers' experiences and perceptions of the 2022 multi-country mpox outbreak PLOS global public health 5(2):e0003704 2025 [PMID: 39951482]
  23. Kebede HB, Mekuria S, Asegid N, Forslund O, Borgfeldt C, Jerkeman M, Mihret A, Abebe T. High-risk human papillomavirus genotypes in previously unscreened reproductive-age women in Ethiopia: A community-based cohort study International journal of cancer 2025 [PMID: 39950735]
  24. Hill K, Robinson LE, Yadav MR, Heidel JR, Nelis M, Kulkarni R, White RS, Hatfield H. The gynecological sequelae of sexual violence in adolescence in the United States: A scoping review International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2025 [PMID: 39950711]
  25. Cotugno N, Sanna M, Amodio D, Morrocchi E, Pighi C, Medri C, Pascucci GR, Santilli V, Manno EC, Zangari P, Rossetti C, Colantoni N, Olivieri G, Emili E, Neri A, Rotili A, Rossi P, Levy O, Putignani L, Palma P. Pre-vaccination immune markers predict response to BNT162b2 mRNA vaccine in vulnerable groups - The CONVERS project, report from a pediatric tertiary hospital Vaccine 49:126778 2025 [PMID: 39947073]
  26. Salência-Ferrão J, Chissaque A, Manhique-Coutinho L, Kenga AN, Cassocera M, de Deus N. Inappropriate use of antibiotics in the management of diarrhoea in children under five years admitted with acute diarrhoea in four provinces of Mozambique 2014-2019 BMC infectious diseases 25(1):209 2025 [PMID: 39939844]
  27. Hesselman MC, Zeeb M, Rusert P, Pasin C, Mamrosh J, Kariuki S, Pichler I, Sickmann M, Kaufmann MM, Schmidt D, Friedrich N, Metzner KJ, Rindler A, Kuster H, Adams C, Thebus R, Huber M, Yerly S, Leuzinger K, Perreau M, Koller R, Dollenmaier G, Frigerio S, Westfall DH, Deng W, deCamp AC, Juraska M, Edupuganti S, Mgodi N, Murrell H, Garrett N, Wagh K, Mullins JI, Williamson C, Moore PL, Günthard HF, Kouyos RD, Trkola A. Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development Cell host & microbe 33(2):279-293.e6 2025 [PMID: 39909038]
  28. Mitchell JL, Buranapraditkun S, Gantner P, Takata H, Dietze K, N'guessan KF, Pollara J, Nohara J, Muir R, Kroon E, Pinyakorn S, Tulmethakaan N, Manasnayakorn S, Chottanapund S, Thantiworasit P, Prueksakaew P, Ratnaratorn N, Puttamaswin S, Nuntapinit B, Fox L, Haddad EK, Paquin-Proulx D, Phanuphak P, Sacdalan CP, Phanuphak N, Ananworanich J, Hsu D, Vasan S, Ferrari G, Chomont N, Trautmann L. Activation of CXCR3(+) Tfh cells and B cells in lymph nodes during acute HIV-1 infection correlates with HIV-specific antibody development Journal of virology :e0153224 2025 [PMID: 39932316]
  29. Chen WY, Chen LJ, Zhou X, Chen WJ, Jiang TT, Wang H, Ma QQ. [Comparative characteristics of HIV/AIDS knowledge belief and behavior among self-reported sexually active female college students in Zhejiang Province in 2018 and 2020] Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 46(2):232-238 2025 [PMID: 39965828]
  30. Sharma A, Kerkhoff AD, Haambokoma M, Shamoya B, Sikombe K, Simbeza SS, Zulu N, Geng EH, Eshun-Wilsonova I, Le Tourneau N, Pry JM. Intention to receive new vaccines post-COVID-19 pandemic among adults and health workers in Lusaka, Zambia Vaccine 50:126846 2025 [PMID: 39938314]
  31. Okurut S, Boulware DR, Manabe YC, Tugume L, Skipper CP, Ssebambulidde K, Rhein J, Musubire AK, Akampurira A, Okafor E, Olobo JO, Janoff EN, Meya DB. Impact of cerebrospinal fluid leukocyte infiltration and activated neuroimmune mediators on survival with HIV-associated cryptococcal meningitis PLoS neglected tropical diseases 19(2):e0012873 2025 [PMID: 39928682]
  32. Waldman JS, Alonzo J, Mann-Jackson L, Aguilar-Palma SK, Garcia M, Smart BD, Rhodes SD. Perspectives of the COVID-19 pandemic and vaccination among racially and ethnically diverse gay, bisexual, and other men who have sex with men with and without HIV in the US South: findings from qualitative individual in-depth interviews BMC infectious diseases 25(1):193 2025 [PMID: 39923031]
  33. Mokhtar JA, Attallah DM, Jiman-Fatani AA, Al-Rabia MW, Alqarni MA, Saleh BH, Amboon MM, Altorki TA, Alkuwaity KK, Abujamel T, Kaki R, Albarakati TN, Daghistani H, Ismail MA, Alharbi O, Abu IIM, Alfadil A, Ibrahem K, Mufrrih M, Sait AM. Dynamic Challenges of Active Tuberculosis: Prevalence and Risk Factors of Co-Infection in Clinical and Microbiological Characteristics at King Abdulaziz University Hospital, Jeddah, Saudi Arabia International journal of general medicine 18:627-641 2025 [PMID: 39935710]
  34. Bender Ignacio R, Kitahata M, Montaño M, Shapiro A. Mpox in People with HIV: Prioritizing Interventions for those without HIV Viral Suppression Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2025 [PMID: 39919043]
  35. Gedion K, Blackwood E, Mwobobia J, Semali I, Moshi MJ, Owibingire S, Mwaiswelo RO, Mashalla Y, Ferrari G, Bartlett J, Osazuwa-Peters N. HIV, HPV, and Oral Health in Tanzania: A scoping review medRxiv : the preprint server for health sciences 2025 [PMID: 39973979]
  36. McClymont E, Wong JMH, Forward L, Blitz S, Barrett J, Bogler T, Boucoiran I, Castillo E, D'Souza R, El-Chaâr D, Fadel SA, Gantt S, Kuret V, Ogilvie G, Poliquin V, Sadarangani M, Scott H, Snelgrove JW, Tunde-Byass M, Money D. Acceptance and preference between respiratory syncytial virus vaccination during pregnancy and infant monoclonal antibody among pregnant and postpartum persons in Canada Vaccine 50:126818 2025 [PMID: 39919449]
  37. Jennings MC, Nabia S, Morgan C, Nduka CC, Brotherton J, Holloway M, Bagshaw K, Bloem P, Wonodi C. Realist review of low- to upper-middle-income country experiences on integration of HPV vaccination with other adolescent health services Vaccine 50:126833 2025 [PMID: 39919446]
  38. Ramaswami R, Kask AS, D'Amico L, Menon MP, Lurain K, Yarchoan R, Ekwede I, Couey P, Burnham E, Angeldekao A, Ha Lee B, Kaiser JC, Cheever M, Uldrick TS, Kwok LL, Wright A, Fling SP, Wang CJ. Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma Journal for immunotherapy of cancer 13(2) 2025 [PMID: 39915263]
  39. Gonelli CA, King HAD, Ko S, Fennessey CM, Iwamoto N, Mason RD, Heimann A, Flebbe DR, Todd JP, Foulds KE, Keele BF, Lifson JD, Koup RA, Roederer M. Antibody prophylaxis may mask subclinical SIV infections in macaques Nature 2025 [PMID: 39910294]
  40. Chemaitelly H, Ayoub HH, Coyle P, Tang P, Hasan MR, Yassine HM, Al Thani AA, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron Nature 2025 [PMID: 39910292]
  41. Tan R, Miauton A, Tebib N, Bagley ML, Delacretaz R, Heiniger C, Bodenmann P, De Vallière S. [Infectious disease screening of asylum seekers and refugees in Switzerland] Revue medicale suisse 21(904):231-236 2025 [PMID: 39908152]
  42. Razavi HA, Waked I, Qureshi H, Kondili LA, Duberg AS, Aleman S, Tanaka J, Lazarus JV, Low-Beer D, Abbas Z, Rached AA, Aghemo A, Aho I, Akarca US, Al-Busafi SA, Al-Hamoudi WK, Al-Naamani K, Alaama AS, Aldar MM, Alghamdi M, Gonzalez MA, Alserehi H, Anand AC, Asselah T, Assiri AM, Athanasakis K, Atugonza R, Ben-Ari Z, Berg T, Brandão-Mello CE, Brown ASM, Brown KA, Brown RS Jr, Bruggmann P, Brunetto MR, Buti M, Cheinquer H, Christensen PB, Chulanov V, Cisneros Garza LE, Coffin CS, Coppola N, Craxi A, Crespo J, Cui F, Dalgard O, De La Torre A, De Ledinghen V, Dieterich D, Drazilova S, Dufour JF, El-Kassas M, Elbadri M, Esmat G, Mur RE, Eurich B, Faini D, Ferreira PRA, Flisiak R, Frankova S, Gaeta GB, Gamkrelidze I, Gane EJ, Garcia V, García-Samaniego J, Gemilyan M, Gottfredsson M, Gschwantler M, Gurski APM, Hajarizadeh B, Hamid SS, Hatzakis A, Hercun J, Hockicková I, Huang JF, Hunyady B, Hutchinson SJ, Ishikawa N, Izumi K, Izzi A, Janicko M, Jarcuska P, Jeruma A, Johannessen A, Kaliaskarova KS, Kao JH, Kielland KB, Kodjoh N, Kottilil S, Kristian P, Kwo PY, Lagging M, Lam H, Lázaro P, Lee MH, Lens S, Liakina V, Lim YS, Makara M, Manns M, Manzengo CM, Memon S, Mendes-Correa MC, Messina V, Midgard H, Murphy N, Musabaev E, Naveira MCM, Nde H, Negro F, Nim N, Ocama P, Olafsson S, Omuemu CE, Pamplona JJ, Pan CQ, Papatheodoridis GV, Pimenov N, Poustchi H, Quaranta MG, Ramji A, Rautiainen H, Razavi-Shearer DM, Razavi-Shearer K, Ridruejo E, Ríos-Hincapié CY, Sadirova S, Sanai FM, Sarrazin C, Sarybayeva G, Schréter I, Seguin-Devaux C, Sereno LS, Shiha G, Smith J, Soliman R, Sonderup MW, Spearman CW, Stauber RE, Stedman CAM, Sypsa V, Tacke F, Terrault NA, Tolmane I, Van Welzen B, Voeller AS, Waheed Y, Wallace C, Whittaker RN, W-S Wong V, Ydreborg M, Yesmembetov K, Yu ML, Zeuzem S, Zuckerman E. Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies Journal of hepatology 2025 [PMID: 39914746]
  43. Ciabattini A, Pettini E, Fiorino F, Polvere J, Lucchesi S, Coppola C, Costagli S, Pastore G, Sicuranza A, Tozzi M, Lippi A, Panza F, Bocchia M, Bucalossi A, Garosi G, Bennett D, Bernazzali S, Fabbiani M, Montagnani F, Medaglini D. Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses EBioMedicine 113:105577 2025 [PMID: 39908650]
  44. Mwape RK, Barday MA, van der Zalm MM, Verhagen LM. Overview of mucosal immunity and respiratory infections in children: a focus on Africa Current opinion in pediatrics 2025 [PMID: 39907513]
  45. Ugwu CLJ, Bragazzi NL, Wu J, Kong JD, Asgary A, Orbinski J, Woldegerima WA. Risk factors associated with human Mpox infection: a systematic review and meta-analysis BMJ global health 10(2) 2025 [PMID: 39900427]
  46. Aziz AM. Preventing bloodborne pathogen transmission in community nursing practice British journal of community nursing 30(2):90-94 2025 [PMID: 39898639]
  47. Hota M, Wondeu ALD, Abakar MF, Dezoumbe K, Abdelrazakh F, Atturo S, Naïbeï N, Cappelli G, Mennechet F, Yandai FH, Abdallah DH, Edgard ZRF, Boukar A, Moussa CA, Yaya IM, Hamad MI, Armand N, Honorine N, Frederic K, Moustapha AA, Daniel YM, Alim AM, Grene M, Djarma O, Suitombaye NY, Akouya A, Choua O, Dzomo GRT, Djimtoïbaye D, Colizzi V, Moussa MA, Giovanetti M. Integrated Seroprevalence and Genome-Based Study of SARS-CoV-2 Viral Strains in N'Djamena: Insights Into Chad's COVID-19 Epicenter Journal of medical virology 97(2):e70234 2025 [PMID: 39967351]
  48. Lu Z, Dong B, Yao P, Huang Y, Fu L, Wang B, Huang X, Mao X, Xu S, Liu S, Sun P, Zou H. Characteristics of Human Papillomavirus Prevalence and Infection Patterns Among Women Aged 35-65 in Fujian Province, China: A Nine-Year Retrospective Observational Study Journal of medical virology 97(2):e70238 2025 [PMID: 39963849]
  49. Li Y, Zhao F, Wu D, Qin C, Lu Y, Yang Y, Wang H, Lu C, Qiu S, Jiang W, Yan Y, Geng X, Rong H, Ji N, Lv N, Li Y, Li J. Prevalence of Human Papillomavirus and Genotype Distribution in Chinese Men: A Systematic Review and Meta-Analysis Cancer medicine 14(4):e70686 2025 [PMID: 39960180]
  50. Bourne J, Sawry S, Le Roux J, Fairlie L, Barnabas S, Cutland CL. Vaccine Utilization and Timing of Administration in Pregnant Women: A South African Perspective The Pediatric infectious disease journal 44(2S):S85-S89 2025 [PMID: 39951080]
  51. Zane GK, Barbee LA, Duerr A, Golden MR, Manhart LE, Dimitrov D, Khosropour C. High Incidence and Duration of Antibiotic Use Among a Cohort of Men Who Have Sex With Men in Seattle, Washington Open forum infectious diseases 12(2):ofaf051 2025 [PMID: 39935960]
  52. Williams RS, Byamugisha AM, Davis-Ewart L, Valentin OR, Dilworth SE, Grov C, Carrico AW. On the fence: Factors associated with COVID-19 vaccine hesitancy among sexually Minoritized men who use substances in the United States Preventive medicine reports 50:102986 2025 [PMID: 39911834]
  53. Agroia H, Mousli L, Nangia D. A holistic evaluation of sexual health disease investigation: case study of the 2022 Mpox outbreak in Santa Clara County, California Sexual health 22 2025 [PMID: 39903602]
  54. Garrett N, Tapley A, Hudson A, Dadabhai S, Zhang B, Mgodi NM, Andriesen J, Takalani A, Fisher LH, Kee JJ, Magaret CA, Villaran M, Hural J, Andersen-Nissen E, Ferarri G, Miner MD, Le Roux B, Wilkinson E, Lessells R, de Oliveira T, Odhiambo J, Shah P, Polakowski L, Yacovone M, Samandari T, Chirenje Z, Elyanu PJ, Makhema J, Kamuti E, Nuwagaba-Biribonwoha H, Badal-Faesen S, Brumskine W, Coetzer S, Dawson R, Delany-Moretlwe S, Diacon AH, Fry S, Gill KM, Ebrahim Hoosain ZA, Hosseinipour MC, Inambao M, Innes C, Innes S, Kalonji D, Kasaro M, Kassim P, Kayange N, Kilembe W, Laher F, Malahleha M, Maluleke VL, Mboya G, McHarry K, Mitha E, Mngadi K, Mda P, Moloantoa T, Mutuluuza CK, Naicker N, Naicker V, Nana A, Nanvubya A, Nchabeleng M, Otieno W, Potgieter EL, Potloane D, Punt Z, Said J, Singh Y, Tayob MS, Vahed Y, Wabwire DO, McElrath MJ, Kublin JG, Bekker LG, Gilbert PB, Corey L, Gray GE, Huang Y, Kotze P. Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study EClinicalMedicine 80:103054 2025 [PMID: 39902315]
  55. Yendewa GA, Olasehinde T, Mulindwa F, Salata RA, Mohareb AM, Jacobson JM. Chronic Hepatitis B and COVID-19 Clinical Outcomes in the United States: A Multisite Retrospective Cohort Study Open forum infectious diseases 12(2):ofaf013 2025 [PMID: 39896985]
  56. Maison DP, Tasissa H, Deitchman A, Peluso MJ, Deng Y, Miller FD, Henrich TJ, Gerschenson M. COVID-19 clinical presentation, management, and epidemiology: a concise compendium Frontiers in public health 13:1498445 2025 [PMID: 39957982]
  57. Liu WD, Chao TL, Chen KH, Sun HY, Lin KY, Chuang YC, Huang YS, Lin CY, Hsu WT, Huang CF, Li GC, Liu WC, Wu CH, Su YC, Chang LH, Lin CY, Wu PY, Chen LY, Chen YT, Luo YZ, Chang HY, Chen YC, Yao Y, Wang JT, Sheng WH, Hsieh SM, Chang SC, Chang SY, Hung CC. Short-term evolution of Mpox-specific IgG and neutralizing antibodies among individuals undergoing MVA-BN vaccination International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases :107830 2025 [PMID: 39894441]
  58. Gschwend MH, Marchese AM, Poelaert D, Warren B, Rousculp MD, Caldera F. Efficacy, immunogenicity, and safety of the Novavax COVID-19 vaccine in immunocompromised patients: A targeted literature review Vaccine 49:126777 2025 [PMID: 39892114]
  59. Hoang CQ, Huynh Nguyen QP, Huynh Nguyen TP, Nguyen HT, Hoang LT, Vu GH, Kim WK, Nguyen HD. Identification of climate-sensitive disease incidences in vietnam: A longitudinal retrospective analysis of infectious disease rates between 2014 and 2022 Heliyon 11(2):e41902 2025 [PMID: 39897828]
  60. Rhoda NR, Turawa E, Engel M, Ayouni I, Zuhlke L, Coetzee D, Mathews S. Prevalence of sudden unexpected death of infants and its subcategories in low- or middle-income countries: a systematic review protocol BMJ open 15(1):e091246 2025 [PMID: 39890148]
  61. Ramezani-Rad P, Cottrell CA, Marina-Zárate E, Liguori A, Landais E, Torres JL, Myers A, Lee JH, Baboo S, Flynn C, McKenney K, Salcedo E, Zhou X, Kalyuzhniy O, Georgeson E, Phelps N, Lu D, Eskandarzadeh S, Menis S, Kubitz M, Groschel B, Alavi N, Jackson AM, Lee WH, Tran AS, Ben-Akiva E, Michaels KK, Diedrich JK, Enemuo CA, Lewis V, Pradhan A, Kasturi SP, Schiffner T, Steichen JM, Carnathan DG, Himansu S, Yates JR, Paulson JC, Ozorowski G, Irvine DJ, Silvestri G, Sok D, Ward AB, Crotty S, Schief WR. Vaccination with mRNA-encoded membrane-bound HIV Envelope trimer induces neutralizing antibodies in animal models bioRxiv : the preprint server for biology 2025 [PMID: 39896562]
  62. Miranda-Hernandez S, Kumar M, Henderson A, Graham E, Tan X, Taylor J, Meehan M, Ceja Z, Del Pozo-Ramos L, Pan Y, Tsui E, Donovan ML, Rentería ME, Flores-Valdez MA, Blumenthal A, Nguyen Q, Subbian S, Field MA, Kupz A. CD8 (+) T cells mediate vaccination-induced lymphatic containment of latent Mycobacterium tuberculosis infection following immunosuppression, while B cells are dispensable bioRxiv : the preprint server for biology 2025 [PMID: 39896630]
  63. Nohara J, Evangelous T, Berry M, Beck W, Mudrak S, Jha S, Reeves RK, Wiehe KJ, Pollara J, Tomaras GD, Bradley T, Ferrari G. Increased Chemokine Production is a Hallmark of Rhesus Macaque Natural Killer Cells Mediating Robust Anti-HIV Envelope-Specific Antibody-Dependent Cell-Mediated Cytotoxicity Pathogens & immunity 10(1):49-79 2024 [PMID: 39911143]
  64. Foláyan MO, Dubé K, Ndembi N. Standard of prevention for infectious diseases' prevention clinical trials during pandemics: learning lessons for global policies from biomedical HIV prevention clinical trials and a case study of COVID-19 Frontiers in public health 12:1539840 2024 [PMID: 39906399]
  65. El-Badry E, Chen L, Ghneim K, Li Z, Brooks K, Rhodes J, Sekaly R, Kilembe W, Allen S, Wu H, Hunter E. Heightened expression of type I interferon signaling genes in CD4(+) T cells from acutely HIV-1-infected women is associated with lower viral loads Frontiers in immunology 15:1507530 2024 [PMID: 39902043]
  66. Jamieson PJ, Shen X, Abu-Shmais AA, Wasdin PT, Janowska K, Edwards RJ, Scapellato G, Richardson SI, Manamela NP, Liu S, Barr M, Gillespie RA, Mimms J, Suryadevara N, Sornberger TA, Zost S, Parks R, Flaherty S, Janke AK, Howard BN, Suresh YP, Ruprecht RM, Crowe JE, Carnahan RH, Bailey JR, Masaru K, Haynes BF, Moore PL, Acharya P, Montefiori DC, Kalams SA, Lu S, Georgiev IS. Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity bioRxiv : the preprint server for biology 2025 [PMID: 39896680]
  67. Dadwal S, Dhar S, Baghel K, Mishra A, Mehrotra S, Prajapati VK. From past to present: The evolution of immunotherapy and its modern modalities Advances in protein chemistry and structural biology 144:1-32 2025 [PMID: 39978965]
  68. Ninga X, Sun Y, Pan Y, Gilbert PB. Regression analysis of semiparametric Cox-Aalen transformation models with partly interval-censored data Electronic journal of statistics 19(1):240-290 2025 [PMID: 39959858]
  69. Mauas R, Rolón MJ, Montaldo F, Lopardo G, Fiori A, Tisné Á, Obieta E, Pelaez S, Cuini R, Cacciari V, Greco MM, Copertari G, Calanni L, Parenti P, Castro G, Erviti A, Brizuela M, Rombini MF, Bottaro E, Cecchini D, Cassetti I. Clinical and epidemiological characteristics of the 2022-2023 Mpox outbreak in Buenos Aires, Argentina Medicina 85(1):64-77 2025 [PMID: 39900050]
  70. Meisner A, Xia F, Chan KCG, Mayer K, Wheeler D, Zangeneh S, Donnell D. Estimating the effect of pre-exposure prophylaxis in Black men who have sex with men International journal of epidemiology 54(1) 2024 [PMID: 39916344]
  71. . Interferon-Gamma Release Assay Testing for Latent Tuberculosis Infection: A Health Technology Assessment Ontario health technology assessment series 24(11):1-183 2024 [PMID: 39911267]
  72. Mahdisoltani S, Murugan P, Chakraborty AK, Kardar M. Minimal framework for optimizing vaccination protocols targeting highly mutable pathogens Physical review. E 110(6-1):064137 2024 [PMID: 39916243]
  73. SeyedAlinaghi S, Pashaei A, Tantuoyir MM, Karimi A, Mojdeganlou H, Nazarian N, Vahedi F, Afzalian A, Shobeiri P, Dashti M, Ghasemzadeh A, Mirzapour P, Nooralioghli Parikhani S, Mehraeen E. Safety and Adverse Effects Related to COVID-19 Viral Vector Vaccines: A Systematic Review Tanaffos 23(2):102-114 2024 [PMID: 39959793]

Lassa virus

  1. Sacramento CQ, Bott R, Huang Q, Eaton B, Postnikova E, Sabir AJ, Argade MD, Ratia K, Anantpadma M, Carlier PR, Ly H, Liang Y, Rong L. Recombinant Pichinde reporter virus as a safe and suitable surrogate for high-throughput antiviral screening against highly pathogenic arenaviruses Antiviral research :106117 2025 [PMID: 39970958]

Machupo virus

  1. Sacramento CQ, Bott R, Huang Q, Eaton B, Postnikova E, Sabir AJ, Argade MD, Ratia K, Anantpadma M, Carlier PR, Ly H, Liang Y, Rong L. Recombinant Pichinde reporter virus as a safe and suitable surrogate for high-throughput antiviral screening against highly pathogenic arenaviruses Antiviral research :106117 2025 [PMID: 39970958]

Marburg virus

  1. Hunter N, Rathish B. Marburg Virus Disease 2025 [PMID: 35201704]

Mycobacterium tuberculosis (tuberculosis)

  1. Guo F, Song Y, Dong S, Wei J, Li B, Xu T, Wang H. Characterization and anti-tuberculosis effects of γδ T cells expanded and activated by Mycobacterium tuberculosis heat-resistant antigen Virulence 16(1):2462092 2025 [PMID: 39921673]
  2. Zhou Z, van Hooij A, van Dijk JHM, Musch N, Pierneef L, Khalid H, Franken K, Holder T, Watt N, Michel AL, Codée JDC, Vordermeier M, Corstjens PLAM, van der Heijden EMDL, Hope JC, Geluk A. Anti-phenolic glycolipid antibodies in Mycobacterium bovis infected cattle One health (Amsterdam, Netherlands) 20:100982 2025 [PMID: 39974705]
  3. Simonson AW, Zeppa JJ, Bucsan AN, Chao MC, Pokkali S, Hopkins F, Chase MR, Vickers AJ, Sutton MS, Winchell CG, Myers AJ, Ameel CL, Kelly RJ, Krouse B, Hood LE, Li J, Lehman CC, Kamath M, Tomko J, Rodgers MA, Donlan R, Chishti H, Borish HJ, Klein E, Scanga CA, Fortune SM, Lin PL, Maiello P, Roederer M, Darrah PA, Seder RA, Flynn JL. Intravenous BCG-mediated protection against tuberculosis requires CD4+ T cells and CD8α+ lymphocytes The Journal of experimental medicine 222(4) 2025 [PMID: 39912921]
  4. Tabata K, Miyazaki O, Imai A, Okamoto R, Miyasaka M, Tsutsumi Y, Anami Y, Seki A, Ikuse T, Kawai T, Ishikawa T, Haga C, Yoshioka T, Nosaka S. Infantile BCG osteomyelitis ultimately diagnosed as a result of trauma Radiology case reports 20(3):1784-1789 2025 [PMID: 39898337]
  5. Wang Z, Guo Z, Zhang Q, Yang C, Shi X, Wen Q, Xue Y, Zhang Z, Wang J. Relationship between iron deficiency and severity of tuberculosis: Influence on T cell subsets iScience 28(2):111709 2025 [PMID: 39898042]
  6. Díaz-Otero F, Jaramillo-Meza L, Manzo-Sandoval A, Olguín-Alor R, Diosdado-Vargas F. Comparative longitudinal analysis of T lymphocyte subpopulations in calves vaccinated with different doses of BCG-Phipps or with culture filtrate protein extract of Mycobacterium bovis in a natural transmission setting BMC veterinary research 21(1):78 2025 [PMID: 39972321]
  7. Sharma S, Moudgil A, Grewal J, Khatri P, Sharma V, Premkumar M, Bal A, Banerjee D, Patil AN. Development and validation of BCG vaccine-induced novel granulomatous liver injury preclinical animal model Animal models and experimental medicine 2025 [PMID: 39968771]
  8. Li H, Ji J, Qu M, Ma X, Zuo Y, Tang M, Zeng L, Li H. Isolation and characterization of a protective monoclonal antibody targeting outer membrane protein (OmpA) against tuberculosis Microbiology spectrum :e0294224 2025 [PMID: 39964152]
  9. Wang Z, Guo Z, Wang W, Zhang Q, Song S, Xue Y, Zhang Z, Wang J. Prediction of tuberculosis treatment outcomes using biochemical makers with machine learning BMC infectious diseases 25(1):229 2025 [PMID: 39962412]
  10. Lukeman H, Al-Wassiti H, Fabb SA, Lim L, Wang T, Britton WJ, Steain M, Pouton CW, Triccas JA, Counoupas C. An LNP-mRNA vaccine modulates innate cell trafficking and promotes polyfunctional Th1 CD4(+) T cell responses to enhance BCG-induced protective immunity against Mycobacterium tuberculosis EBioMedicine 113:105599 2025 [PMID: 39955975]
  11. Hazra D, Rahman S, Ganguly M, Das AK, Roychowdhury A. Molecular dynamics simulation shows enhanced stability in scaffold-based macromolecule, designed by protein engineering: a novel methodology adapted for converting Mtb Ag85A to a multi-epitope vaccine Journal of molecular modeling 31(3):84 2025 [PMID: 39954152]
  12. Alfahad L, Khushaim A, Alhabeeb W, Alzayed A, Almushayqih M. BCGitis and BCGosis spectrum of imaging findings in immunocompromised pediatric patients Pediatric radiology 2025 [PMID: 39953302]
  13. Chen WY, Chen LJ, Zhou X, Chen WJ, Jiang TT, Wang H, Ma QQ. [Comparative characteristics of HIV/AIDS knowledge belief and behavior among self-reported sexually active female college students in Zhejiang Province in 2018 and 2020] Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 46(2):232-238 2025 [PMID: 39965828]
  14. Sharma A, Kerkhoff AD, Haambokoma M, Shamoya B, Sikombe K, Simbeza SS, Zulu N, Geng EH, Eshun-Wilsonova I, Le Tourneau N, Pry JM. Intention to receive new vaccines post-COVID-19 pandemic among adults and health workers in Lusaka, Zambia Vaccine 50:126846 2025 [PMID: 39938314]
  15. Mokhtar JA, Attallah DM, Jiman-Fatani AA, Al-Rabia MW, Alqarni MA, Saleh BH, Amboon MM, Altorki TA, Alkuwaity KK, Abujamel T, Kaki R, Albarakati TN, Daghistani H, Ismail MA, Alharbi O, Abu IIM, Alfadil A, Ibrahem K, Mufrrih M, Sait AM. Dynamic Challenges of Active Tuberculosis: Prevalence and Risk Factors of Co-Infection in Clinical and Microbiological Characteristics at King Abdulaziz University Hospital, Jeddah, Saudi Arabia International journal of general medicine 18:627-641 2025 [PMID: 39935710]
  16. Schwarzlose-Schwarck S, Reinwald M, Bauer T, Hentschel F, Kiderlen T, Zapf D, Herbst V, Lüth S, Krieger D, Dammermann W. Evaluation of three novel antigens and costimulatory agents for improvement of M. Tuberculosis specific interferon gamma release assays BMC infectious diseases 25(1):188 2025 [PMID: 39920589]
  17. Hoerter A, Petrucciani A, Bonifacio J, Arnett E, Schlesinger LS, Pienaar E. Timing matters in macrophage/CD4+ T cell interactions: an agent-based model comparing Mycobacterium tuberculosis host-pathogen interactions between latently infected and naïve individuals mSystems :e0129024 2025 [PMID: 39918314]
  18. Fromsa A, Conlan AJK, Srinivasan S, Gumi B, Bedada W, Zeleke M, Worku D, Lakew M, Tadesse B, Bayissa B, Sirak A, Abdela MG, Mekonnen GA, Chibssa T, Veerasami M, Jones GJ, Vordermeier HM, Juleff N, Wood JLN, Ameni G, Kapur V. Comparative performance of tuberculin and defined-antigen cocktails for detecting bovine tuberculosis in BCG-vaccinated cattle in natural settings Scientific reports 15(1):4564 2025 [PMID: 39915566]
  19. Ismail N, Moultrie H, Mwansa-Kambafwile J, Copas A, Izu A, Moyo S, Skinner D, Ismail F, Gosce L, Omar SV, Abubakar I, Madhi SA. Effects of conditional cash transfers and pre-test and post-test tuberculosis counselling on patient outcomes and loss to follow-up across the continuum of care in South Africa: a randomised controlled trial The Lancet. Infectious diseases 2025 [PMID: 39923785]
  20. Chen MH, Jiang J, Chen H, Wu RH, Xie W, Dai SZ, Zheng WP, Tan GH, Huang FY. Reinforcing cancer immunotherapy with engineered porous hollow mycobacterium tuberculosis loaded with tumor neoantigens Journal for immunotherapy of cancer 13(2) 2025 [PMID: 39915006]
  21. Kollmann TR, Amenyogbe N, Schaltz-Buchholzer F, Bæk O, Campbell J, Lynn DJ, Campbell AJ, Aaby P, Stabell Benn C, Netea MG, Divangahi M. Is systemic dissemination of BCG following neonatal vaccination required for protection against M. tuberculosis? The Journal of infectious diseases 2025 [PMID: 39913242]
  22. Tan R, Miauton A, Tebib N, Bagley ML, Delacretaz R, Heiniger C, Bodenmann P, De Vallière S. [Infectious disease screening of asylum seekers and refugees in Switzerland] Revue medicale suisse 21(904):231-236 2025 [PMID: 39908152]
  23. Razavi HA, Waked I, Qureshi H, Kondili LA, Duberg AS, Aleman S, Tanaka J, Lazarus JV, Low-Beer D, Abbas Z, Rached AA, Aghemo A, Aho I, Akarca US, Al-Busafi SA, Al-Hamoudi WK, Al-Naamani K, Alaama AS, Aldar MM, Alghamdi M, Gonzalez MA, Alserehi H, Anand AC, Asselah T, Assiri AM, Athanasakis K, Atugonza R, Ben-Ari Z, Berg T, Brandão-Mello CE, Brown ASM, Brown KA, Brown RS Jr, Bruggmann P, Brunetto MR, Buti M, Cheinquer H, Christensen PB, Chulanov V, Cisneros Garza LE, Coffin CS, Coppola N, Craxi A, Crespo J, Cui F, Dalgard O, De La Torre A, De Ledinghen V, Dieterich D, Drazilova S, Dufour JF, El-Kassas M, Elbadri M, Esmat G, Mur RE, Eurich B, Faini D, Ferreira PRA, Flisiak R, Frankova S, Gaeta GB, Gamkrelidze I, Gane EJ, Garcia V, García-Samaniego J, Gemilyan M, Gottfredsson M, Gschwantler M, Gurski APM, Hajarizadeh B, Hamid SS, Hatzakis A, Hercun J, Hockicková I, Huang JF, Hunyady B, Hutchinson SJ, Ishikawa N, Izumi K, Izzi A, Janicko M, Jarcuska P, Jeruma A, Johannessen A, Kaliaskarova KS, Kao JH, Kielland KB, Kodjoh N, Kottilil S, Kristian P, Kwo PY, Lagging M, Lam H, Lázaro P, Lee MH, Lens S, Liakina V, Lim YS, Makara M, Manns M, Manzengo CM, Memon S, Mendes-Correa MC, Messina V, Midgard H, Murphy N, Musabaev E, Naveira MCM, Nde H, Negro F, Nim N, Ocama P, Olafsson S, Omuemu CE, Pamplona JJ, Pan CQ, Papatheodoridis GV, Pimenov N, Poustchi H, Quaranta MG, Ramji A, Rautiainen H, Razavi-Shearer DM, Razavi-Shearer K, Ridruejo E, Ríos-Hincapié CY, Sadirova S, Sanai FM, Sarrazin C, Sarybayeva G, Schréter I, Seguin-Devaux C, Sereno LS, Shiha G, Smith J, Soliman R, Sonderup MW, Spearman CW, Stauber RE, Stedman CAM, Sypsa V, Tacke F, Terrault NA, Tolmane I, Van Welzen B, Voeller AS, Waheed Y, Wallace C, Whittaker RN, W-S Wong V, Ydreborg M, Yesmembetov K, Yu ML, Zeuzem S, Zuckerman E. Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies Journal of hepatology 2025 [PMID: 39914746]
  24. Marcantonio E, Burger AD, Chang KH, Hoffmann FW, Fu Y, Khadka VS, Smagghe BJ, Deng Y, Hoffmann PR, Prisic S. Zinc-limited Mycobacterium tuberculosis stimulate distinct responses in macrophages compared with standard zinc-replete bacteria Infection and immunity :e0057824 2025 [PMID: 39903447]
  25. Chen C, Xue H, Horsburgh CR, Amour M, Hatherill M, Tameris M, von Reyn CF, Rees C, Shen Y, McShane H, García-Basteiro AL, Liu D, Wang Y, Nathavitharana RR, Graviss EA, Shao Y, Liu Q, Lu W, Zhu L, Martinez L. Trajectories of interferon-gamma release assay results over two years in independent cohorts from China, South Africa, Tanzania, and the United States Chest 2025 [PMID: 39909102]
  26. Lu Z, Dong B, Yao P, Huang Y, Fu L, Wang B, Huang X, Mao X, Xu S, Liu S, Sun P, Zou H. Characteristics of Human Papillomavirus Prevalence and Infection Patterns Among Women Aged 35-65 in Fujian Province, China: A Nine-Year Retrospective Observational Study Journal of medical virology 97(2):e70238 2025 [PMID: 39963849]
  27. Kirakosyan O, Reimann M, Andersen AB, Bjarnason A, Bakos Á, Dyrhol-Riise AM, McLaughlin AM, Nita C, Pieridou D, Chesov D, Davidavičienė EV, Günther G, Atshemyan H, Muylle I, Solovic I, Bruchfeld J, Manika K, Kuksa L, Codecasa LR, Stosic M, Skowroński M, Makek MJ, Fréchet Jachym M, Knappik M, Santin M, Yatskevich N, Konstantynovska O, Akkerman O, Svetina P, Viiklepp P, Duarte R, Zeynel S, Togonidze T, Vasankari T, Parris V, Özkara Ş, Lange C, Brehm TT. Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in Europe IJTLD open 2(2):101-106 2025 [PMID: 39959402]
  28. Shah R, Rao A, Gunay S, Kulkarni S. Tuberculous Osteomyelitis of the Coracoid Process Presenting as Shoulder Pain: A Case Report Journal of orthopaedic case reports 15(2):188-192 2025 [PMID: 39957924]
  29. Quincer EM, Gobezayehu AG, Belew ML, Endalamaw LA, Tesfaye YA, Shiferaw M, Hussen SA, Cranmer JN, Omer SB, Cranmer LM. High Intention to Vaccinate Against Tuberculosis During Pregnancy and Lactation: Understanding Vaccine-specific Maternal Immunization Acceptance in Amhara, Ethiopia The Pediatric infectious disease journal 44(2S):S135-S140 2025 [PMID: 39951091]
  30. Dale KD, Denholm JT. Optimising the M72/AS01E tuberculosis vaccine candidate phase 3 trial based on the phase 2b trial results Vaccine 49:126816 2025 [PMID: 39892110]
  31. Gurmessa SK, Choi HG, Back YW, Jiang Z, Pham TA, Choi S, Kim HJ. Novel fusion protein REA induces robust prime protection against tuberculosis in mice NPJ vaccines 10(1):20 2025 [PMID: 39890787]
  32. Dahiya P, Bisht MK, Mukhopadhyay S. Role of PE family of proteins in mycobacterial virulence: Potential on anti-TB vaccine and drug design International reviews of immunology :1-16 2025 [PMID: 39889764]
  33. Ehtram A, Shariq M, Quadir N, Jamal S, Pichipalli M, Zarin S, Sheikh JA, Ehtesham NZ, Hasnain SE. Deciphering the functional roles of PE18 and PPE26 proteins in modulating Mycobacterium tuberculosis pathogenesis and immune response Frontiers in immunology 16:1517822 2025 [PMID: 39949767]
  34. Hoang CQ, Huynh Nguyen QP, Huynh Nguyen TP, Nguyen HT, Hoang LT, Vu GH, Kim WK, Nguyen HD. Identification of climate-sensitive disease incidences in vietnam: A longitudinal retrospective analysis of infectious disease rates between 2014 and 2022 Heliyon 11(2):e41902 2025 [PMID: 39897828]
  35. Rhoda NR, Turawa E, Engel M, Ayouni I, Zuhlke L, Coetzee D, Mathews S. Prevalence of sudden unexpected death of infants and its subcategories in low- or middle-income countries: a systematic review protocol BMJ open 15(1):e091246 2025 [PMID: 39890148]
  36. Li L, Zhang X, Yan H, Dai M, Gao H, Wang Y, Jiang P, Dai E. Different immunological characteristics of asymptomatic and symptomatic COVID-19 patients without vaccination in the acute and convalescence stages PeerJ 13:e18451 2025 [PMID: 39897496]
  37. Wang W, Wang X, Chen S, Li J, Cheng Q, Zhang Y, Wu Q, Liu K, Jiang X, Chen B. Prevalence and clinical profile of comorbidity among newly diagnosed pulmonary tuberculosis patients: a multi-center observational study in eastern China Frontiers in medicine 12:1446835 2025 [PMID: 39935798]
  38. Yun JS, Shin E, Lee YR, Lee JA, Lee H, Kim JS, Shin SJ, Ha SJ, Lee SW, Kim D, Yoo JS, Jeong HS. Immunogenicity and protective efficacy of a multi-antigenic adenovirus-based vaccine candidate against Mycobacterium tuberculosis Frontiers in microbiology 16:1492268 2025 [PMID: 39927262]
  39. Miranda-Hernandez S, Kumar M, Henderson A, Graham E, Tan X, Taylor J, Meehan M, Ceja Z, Del Pozo-Ramos L, Pan Y, Tsui E, Donovan ML, Rentería ME, Flores-Valdez MA, Blumenthal A, Nguyen Q, Subbian S, Field MA, Kupz A. CD8 (+) T cells mediate vaccination-induced lymphatic containment of latent Mycobacterium tuberculosis infection following immunosuppression, while B cells are dispensable bioRxiv : the preprint server for biology 2025 [PMID: 39896630]
  40. Li X, Zhu Y, Lu Y, Wu K, Che Y, Wang X, Wang W, Gao J, Gao J, Liu Z, Zhou Z. Population genetic analysis of clinical Mycobacterium abscessus complex strains in China Frontiers in cellular and infection microbiology 14:1496896 2024 [PMID: 39902180]
  41. Cuenca-Lara P, Blay-Benach M, Cervera Z, Melgarejo C, Moraleda J, Sevilla IA, Garrido JM, Singh M, Jones GJ, Pérez de Val B. Effects of different vaccination regimes on the immunodiagnosis of tuberculosis in goats and evaluation of defined antigens Frontiers in veterinary science 11:1524461 2024 [PMID: 39931351]
  42. Hosseini SA, Hashemi S, Siamian D, Asghari A, Fathollahzadeh M, Majidiani H, Shahraki I, Safari MH. Discovery of novel vaccine candidates based on the immunogenic epitopes derived from Toxoplasma membrane proteins Clinical and experimental vaccine research 14(1):86-8100 2025 [PMID: 39927227]
  43. Kluemper A, Morris K, Mellon MJ. From plague to the promise: The journey of Bacille Calmette-Guérin Bladder (San Francisco, Calif.) 11(4):e21200022 2024 [PMID: 39944512]
  44. . Interferon-Gamma Release Assay Testing for Latent Tuberculosis Infection: A Health Technology Assessment Ontario health technology assessment series 24(11):1-183 2024 [PMID: 39911267]
  45. Clark RA, Portnoy A, Weerasuriya CK, Sumner T, Bakker R, Harris RC, Rade K, Mattoo SK, Tumu D, Menzies NA, White RG. Estimating the potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study The Lancet regional health. Southeast Asia 31:100424 2024 [PMID: 39957772]
  46. Kumari A, Bali IK, Chauhan A, Chitkara F, Wadhera D. Histopathological Insights into Granulomatous Lesions: A Comprehensive Study Journal of pharmacy & bioallied sciences 16(Suppl 4):S3781-S3783 2024 [PMID: 39926823]
  47. Aghabeiglooei Z, Rezaei Orimi J, Marghoub Khajeh S, Mojahedi M, Ghaffari F. Consequences of Infectious Disease Outbreaks in Ardabil (1925-1941): A Historical Analysis Archives of Iranian medicine 27(12):710-717 2024 [PMID: 39891460]
  48. Jablonowski K, Hooker B. Adverse outcome detection of childhood administered thimerosal-free HibTITER(®) The International journal of risk & safety in medicine 35(4):301-307 2024 [PMID: 39973418]
  49. Yela E, Puig L, De Odriozola M, Flores-Imbernon À, Girado N, Jacas A, Llopart M, Macías C, Mellado S, Rue X, Sánchez-Encomienda P, Serrats M, Tost J, Turu E. Tuberculin test measurement at 48 and 72 hours: mismatch and clinical significance Revista espanola de sanidad penitenciaria 26(3):92-97 2024 [PMID: 39927806]
  50. Tavakkoli S, Rostami Nejad M, Pourhoseingholi MA, Mirmomeni G, Ghorbani F, Rezaei Tavirani M, Jahani-Sherafat S, EmamHadi MA, Janbazi S, Zali A, Rezaei M, Robati RM. Side Effects of COVID-19 Vaccination Following First and Second Doses: A Cross-Sectional Survey Based on Vaccine-associated Factors Tanaffos 23(2):115-128 2024 [PMID: 39959795]

Plasmodium falciparum (Malaria)

  1. Hickey JM, Sharma N, Fairlamb M, Doering J, Adewunmi Y, Prieto K, Costa G, Wizel B, Levashina EA, Mantis NJ, Julien JP, Joshi SB, Volkin DB. PfCSP-ferritin nanoparticle malaria vaccine antigen formulated with aluminum-salt and CpG 1018® adjuvants: Preformulation characterization, antigen-adjuvant interactions, and mouse immunogenicity studies Human vaccines & immunotherapeutics 21(1):2460749 2025 [PMID: 39903060]
  2. Obi OA, Obiezue RN, Eze D, Adebote DA. Evasive mechanisms of human VSG and PfEMP1 antigens with link to Vaccine scenario: a review Journal of parasitic diseases : official organ of the Indian Society for Parasitology 49(1):13-28 2025 [PMID: 39975623]
  3. Yoo R, Jore MM, Julien JP. Targeting Bottlenecks in Malaria Transmission: Antibody-Epitope Descriptions Guide the Design of Next-Generation Biomedical Interventions Immunological reviews 330(1):e70001 2025 [PMID: 39907429]
  4. Shabani S, Serbus LR. Pfs16: A Key Parasitophorous Vacuole Membrane Protein Crucial for Malaria Parasite Development and Transmission The protein journal 2025 [PMID: 39979562]
  5. Brindley PJ, Hotez PJ, Kamhawi S. Revisiting What Constitutes a Neglected Tropical Disease? PLoS neglected tropical diseases 19(2):e0012794 2025 [PMID: 39977425]
  6. Yanik S, Venkatesh V, Gordy JT, Alameh MG, Meza J, Li Y, Glass E, Flores-Garcia Y, Tam Y, Chaiyawong N, Sarkar D, Weissman D, Markham R, Srinivasan P. iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA NPJ vaccines 10(1):34 2025 [PMID: 39971939]
  7. Kiper E, Ben Hur D, Alfandari D, Camacho AC, Wani NA, Efrat GD, Morandi MI, Goldsmith M, Rotkopf R, Kamyshinsky R, Deshmukh A, Binte Zulkifli NE, Asmari N, Penedo M, Fantner G, Porat Z, Azuri I, Rosenhek-Goldian I, Chitnis CE, Shai Y, Regev-Rudzki N. Antimicrobial Peptides Selectively Target Malaria Parasites by a Cholesterol-Dependent Mechanism The Journal of biological chemistry :108298 2025 [PMID: 39971158]
  8. Liu Y, Richardson S. Can malaria be eliminated? 15 years on Transactions of the Royal Society of Tropical Medicine and Hygiene 2025 [PMID: 39957376]
  9. Alothaid H. Molecular Docking and Pharmacokinetic Properties of Chrysin, Indole-3-carbinol, and Curcumin in the Biological Context of Plasmodium falciparum 3D7 Journal of vector borne diseases 2025 [PMID: 39953857]
  10. Aguirre-Botero MC, Pacios O, Celli S, Aliprandini E, Gladston A, Thiberge JM, Formaglio P, Amino R. Late killing of Plasmodium berghei sporozoites in the liver by an anti-circumsporozoite protein antibody eLife 14 2025 [PMID: 39951341]
  11. Ganeshan H, Huang J, Belmonte M, Belmonte A, Inoue S, Velasco R, Maiolatesi S, Limbach K, Patterson N, Sklar MJ, Soisson L, Epstein JE, Edgel KA, Peters B, Hollingdale MR, Villasante E, Duplessis CA, Sedegah M. Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes PloS one 20(2):e0318098 2025 [PMID: 39946433]
  12. Chua YC, Draper SL, Le S, de Menezes MN, Ganley M, Ge Z, Lee A, Phabmixay T, Hirschmann D, Robinson SA, Tan PS, Tullett KM, Anderson RJ, Jayasinghe D, Cozijnsen A, Lahoud MH, Caminschi I, Beattie L, McFadden GI, Larsen DS, Kaisho T, Gras S, Hermans IF, Compton BJ, Heath WR, Painter GF, Holz LE. Mechanistic insight into the induction of liver tissue-resident memory CD8(+) T cells by glycolipid-peptide vaccination Cell reports 44(2):115295 2025 [PMID: 39946236]
  13. Ko YK, Kagaya W, Yoneoka D, Kongere J, Opiyo V, Oginga J, Omondi P, Musyoka KB, Chan CW, Kanoi BN, Gitaka J, Kaneko A. Where is the hard-to-reach population? Spatial analysis from a cross-sectional study on the access to bed net and malaria vaccine in the Lake Victoria Region, Kenya Malaria journal 24(1):42 2025 [PMID: 39939989]
  14. Salência-Ferrão J, Chissaque A, Manhique-Coutinho L, Kenga AN, Cassocera M, de Deus N. Inappropriate use of antibiotics in the management of diarrhoea in children under five years admitted with acute diarrhoea in four provinces of Mozambique 2014-2019 BMC infectious diseases 25(1):209 2025 [PMID: 39939844]
  15. Mercogliano M, Spatari G, Noviello C, Di Serafino F, Mormile ME, Granvillano G, Iagnemma A, Mimmo R, Schenone I, Raso E, Sanna A, Frasson E, Gallinoro V, Di Pumpo M, Shellah D, Rizzo C, Zotti N. Building evidences in Public Health Emergency Preparedness ("BePHEP" Project)-a systematic review International journal for equity in health 24(1):41 2025 [PMID: 39934889]
  16. Sa JD, Krauss L, Smith L, D'Andrea L, Chan LJ, Abraham A, Kiernan-Walker N, Mazhari R, Lamont M, Lim PS, Sattabongkot J, Lacerda MV, Wini L, Mueller I, Longley RJ, Pymm P, Fleishman SJ, Tham WH. Stabilized designs of the malaria adhesin protein PvRBP2b for use as a potential diagnostic for Plasmodium vivax The Journal of biological chemistry :108290 2025 [PMID: 39938801]
  17. Sharma A, Kerkhoff AD, Haambokoma M, Shamoya B, Sikombe K, Simbeza SS, Zulu N, Geng EH, Eshun-Wilsonova I, Le Tourneau N, Pry JM. Intention to receive new vaccines post-COVID-19 pandemic among adults and health workers in Lusaka, Zambia Vaccine 50:126846 2025 [PMID: 39938314]
  18. Scalsky R, Dwivedi A, Stabler TC, Mbambo G, Ouattara A, Lyke KE, Takala-Harrison S, Silva JC. Whole-genome sieve analysis: Identification of protective malaria antigens by leveraging allele-specific vaccine efficacy Vaccine 50:126783 2025 [PMID: 39923546]
  19. Nema S, Rathore S, Mohmmed A, Malhotra P. Unlocking the potential of blood-stage vaccines for malaria elimination Transactions of the Royal Society of Tropical Medicine and Hygiene 2025 [PMID: 39921411]
  20. Hawadak J, Foko LPK, Nana RRD, Singh V. Novel Nona-Repeat in Plasmodium ovale curtisi Circumsporozoite Protein Circulating in Cameroon Current microbiology 82(3):125 2025 [PMID: 39920482]
  21. Okumu F, Moore SJ, Selvaraj P, Yafin AH, Juma EO, Shirima GG, Majambere S, Hardy A, Knols BGJ, Msugupakulya BJ, Finda M, Kahamba N, Thomsen E, Ahmed A, Zohdy S, Chaki P, DeChant P, Fornace K, Govella N, Gowelo S, Hakizimana E, Hamainza B, Ijumba JN, Jany W, Kafy HT, Kaindoa EW, Kariuki L, Kiware S, Kweka EJ, Lobo NF, Marrenjo D, Matoke-Muhia D, Mbogo C, McCann RS, Monroe A, Ndenga BA, Ngowo HS, Ochomo E, Opiyo M, Reithinger R, Sikaala CH, Tatarsky A, Takudzwa D, Trujillano F, Sherrard-Smith E. Elevating larval source management as a key strategy for controlling malaria and other vector-borne diseases in Africa Parasites & vectors 18(1):45 2025 [PMID: 39915825]
  22. Adigwe OP, Onavbavba G. Acceptance and affordability of malaria vaccines: issues relating to hesitancy and willingness to pay amongst Nigerian parents of under-five children Malaria journal 24(1):36 2025 [PMID: 39915774]
  23. Elsworth B, Ye S, Dass S, Tennessen JA, Sultana Q, Thommen BT, Paul AS, Kanjee U, Grüring C, Ferreira MU, Gubbels MJ, Zarringhalam K, Duraisingh MT. The essential genome of Plasmodium knowlesi reveals determinants of antimalarial susceptibility Science (New York, N.Y.) 387(6734):eadq6241 2025 [PMID: 39913579]
  24. Ali MS, Stockdale L, Sagara I, Zongo I, Yerbanga RS, Mahamar A, Nikièma F, Tapily A, Sompougdou F, Diarra M, Bellamy D, Provstgaard-Morys S, Zoungrana C, Issiaka D, Haro A, Sanogo K, Sienou AA, Kaya M, Traore S, Dicko OM, Kone Y, Yalcouye H, Thera I, Diarra K, Snell P, Ofori-Anyinam O, Ockenhouse C, Lee C, Ewer K, Tinto H, Djimde A, Ouedraogo JB, Dicko A, Chandramohan D, Greenwood B. The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01(E) NPJ vaccines 10(1):26 2025 [PMID: 39915506]
  25. Mwingira F, Matiya D, Chacky F. Knowledge and willingness towards malaria vaccines among caregivers in Dar es Salaam, Tanzania Malaria journal 24(1):35 2025 [PMID: 39910572]
  26. Lawton JG, Zhou AE, Stucke EM, Takala-Harrison S, Silva JC, Travassos MA. Diamonds in the rif: Alignment-free comparative genomics analysis reveals strain-transcendent Plasmodium falciparum antigens amidst extensive genetic diversity Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 129:105725 2025 [PMID: 39920908]
  27. Otun O, Achilonu I. Plasmodium yoelii as a model for malaria: insights into pathogenesis, drug resistance, and vaccine development Molecular biology reports 52(1):208 2025 [PMID: 39907835]
  28. Mohammed AM, Olwal CO, Fossati A, Nyakoe NK, Fabius JM, Gordon M, Polacco BJ, Swaney DL, Awandare GA, Krogan NJ, Bouhaddou M, Bediako Y. Malaria exposure remodels the plasma proteome of Ghanaian children BMC infectious diseases 25(1):157 2025 [PMID: 39901099]
  29. Diawara H, Grant J, Dicko A, Traore S, Issiaka D, Koita F, Datoo M, Sylla M, Dicko AB, Sagara I, Chandramohan D, Hill AV, Greenwood B, Webster J. Acceptability of the R21/Matrix-M malaria vaccine alongside existing malaria interventions in the trial context BMJ global health 10(2) 2025 [PMID: 39900425]
  30. Ouattara A, Andronescu LR, Adams M, Sharma A, Nakajima R, Jain A, Taghavian O, Jasinskas A, Felgner PL, Mathanga DP, Chinkhumba J, Laufer MK, Travassos MA. Choice of Drug for Malaria Prevention During Pregnancy Does Not Affect Infant Serologic Responses to Plasmodium falciparum Erythrocyte Membrane Proteins 1 Open forum infectious diseases 12(2):ofaf037 2025 [PMID: 39963702]
  31. Nyiro JU, Bukusi E, Mureithi MW, Walumbe D, Nyaguara A, Kipkoech C, Nyawanda B, Bigogo G, Otieno N, Aol G, Audi A, Murunga N, Berkley JA, Nokes DJ, Munywoki PK. Prevalence and Predictors of Adverse Birth Outcomes and Their Implications in Assessing the Safety of New Maternal Vaccines in Kenya The Pediatric infectious disease journal 44(2S):S114-S118 2025 [PMID: 39951088]
  32. Wu Y, Chen YC, Liu FF, Li K. The Immunomodulatory Role of Estrogen in Malaria: A Review of Sex Differences and Therapeutic Implications Immunity, inflammation and disease 13(2):e70148 2025 [PMID: 39898752]
  33. Kessy EJ, Olotu AI. Controlled human malaria infection: overview and potential application in the evaluation of transmission-blocking interventions in malaria-endemic areas Malaria journal 24(1):33 2025 [PMID: 39893367]
  34. Zanghí G, Patel H, Smith JL, Camargo N, Bae Y, Hesping E, Boddey JA, Venugopal K, Marti M, Flannery EL, Chuenchob V, Fishbaugher ME, Mikolajczak SA, Roobsoong W, Sattabongkot J, Gupta P, Pazzagli L, Rezakhani N, Betz W, Hayes K, Goswami D, Vaughan AM, Kappe SHI. Genome-wide gene expression profiles throughout human malaria parasite liver stage development in humanized mice Nature microbiology 10(2):569-584 2025 [PMID: 39891010]
  35. Chick JA, Abongdia NN, Shey RA, Apinjoh TO. Computational design, expression, and characterization of a Plasmodium falciparum multi-epitope, multi-stage vaccine candidate (PfCTMAG) Heliyon 11(2):e42014 2025 [PMID: 39906795]
  36. Hoang CQ, Huynh Nguyen QP, Huynh Nguyen TP, Nguyen HT, Hoang LT, Vu GH, Kim WK, Nguyen HD. Identification of climate-sensitive disease incidences in vietnam: A longitudinal retrospective analysis of infectious disease rates between 2014 and 2022 Heliyon 11(2):e41902 2025 [PMID: 39897828]
  37. Kyei-Baafour E, Kusi KA, Owusu-Yeboa E, Issahaque QA, Kumordjie S, Authur FK, Dwomoh D, Singh SK, Dodoo D, Theisen M, Adu B. Wider antibody breadth against multiple Plasmodium falciparum antigens is associated with reduced risk of malaria in a transmission hotspot in southern Ghana International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases :107804 2025 [PMID: 39889952]
  38. Zhang D, Zhao Y, Liu D, Liu F, Liu P, Zhang B, Wu Z, Roobsoong W, Bantuchai S, Thongpoon S, Sripoorote P, Wang M, Cui L, Cao Y. Evaluation of the transmission-blocking potential of Plasmodium vivax antigen Pvg37 using transgenic rodent parasites and clinical isolates Frontiers in cellular and infection microbiology 15:1529770 2025 [PMID: 39925376]
  39. Clark RA, Portnoy A, Weerasuriya CK, Sumner T, Bakker R, Harris RC, Rade K, Mattoo SK, Tumu D, Menzies NA, White RG. Estimating the potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study The Lancet regional health. Southeast Asia 31:100424 2024 [PMID: 39957772]
  40. Aghabeiglooei Z, Rezaei Orimi J, Marghoub Khajeh S, Mojahedi M, Ghaffari F. Consequences of Infectious Disease Outbreaks in Ardabil (1925-1941): A Historical Analysis Archives of Iranian medicine 27(12):710-717 2024 [PMID: 39891460]

Salmonella

  1. Soydam S, Has EG, Sürkaç TN, Akçelik M, Akçelik N. Effects of bcsE, luxS and rfaG genes on the physiology and pathogenicity of Salmonella Typhimurium Archives of microbiology 207(3):63 2025 [PMID: 39961809]
  2. Sun D, Gou H, Zhang Y, Li J, Dai C, Shen H, Chen K, Wang Y, Pan P, Zhu T, Xu C, Shan T, Liao M, Zhang J. Salmonella Typhimurium persistently infects host via its effector SseJ-induced PHB2-mediated mitophagy Autophagy :1-17 2025 [PMID: 39902787]
  3. Law JD, Gao Y, Kovvali S, Thirugnanasambantham P, Wysocki VH, Ahmer BMM, Gopalan V. Identification of inhibitors of the Salmonella FraB deglycase, a drug target FEBS open bio 2025 [PMID: 39945759]
  4. Aganja RP, Bakhsh M, Senevirathne A, Kwon J, Lee JH. Lipopolysaccharide structural modification in Salmonella Gallinarum targeting lipid a deacylation and O-antigen reduces virulence and endotoxicity with competitive protection against a wild-type challenge in chickens Developmental and comparative immunology 165:105343 2025 [PMID: 39952572]
  5. Ji Y, Guo J, Jiang H, Ren W, Geng J, Lei M, Li J, Dang P, Wang Y, Chen X, Zhao T, Lu C, Jia H, Yang J. Enhanced Efficacy of Radiation Therapy against Glioblastoma by Attenuated Salmonella Carrying Co-Expression Plasmids with siRNA-PD-L1 and Endostatin Current cancer drug targets 2025 [PMID: 39931861]
  6. Laneque L, Lambert A, Cayet D, Gilleron C, Courtois E, Cloteau C, Broussard C, Annic B, Bessonnet T, Camberlein E, Sirard JC, Grandjean C. Mutagenesis to Orient Conjugation and Preserve Self-adjuvant Properties of Flagellin in Conjugates Chembiochem : a European journal of chemical biology :e202401002 2025 [PMID: 39918786]
  7. Yeh HY. Epitope mapping of recombinant Salmonella enterica serotype Heidelberg flagellar hook-associated protein by in silico and in vivo approaches BMC veterinary research 21(1):54 2025 [PMID: 39915877]
  8. Peng Y, Wu J, Sun Y, Zhang Y, Wang Q, Shao S. Contrastive-learning of language embedding and biological features for cross modality encoding and effector prediction Nature communications 16(1):1299 2025 [PMID: 39900608]
  9. Getahun Strobel A, Hayes AJ, Wirth W, Mua M, Saumalua T, Cabenatabua O, Soqo V, Rosa V, Wang N, Lacey JA, Hocking D, Valcanis M, Jenney A, Howden BP, Duchene S, Mulholland K, Strugnell RA, Davies MR. Corrigendum: Genetic heterogeneity in the Salmonella Typhi Vi capsule locus: a population genomic study from Fiji Microbial genomics 11(2) 2025 [PMID: 39899357]
  10. Demirtas ED, Barnard R, Lee J, Jit M. A systematised review and evidence synthesis on the broader societal impact of vaccines against Salmonella NPJ vaccines 10(1):21 2025 [PMID: 39893202]
  11. Khanam F, Rickett NY, Ahmmed F, Islam MT, Mbae CK, Im J, Aziz AB, Ongadi B, Chowdhury F, Khan AI, Akter A, Firoj MG, Rahman SIA, Haile K, Park SE, Mwebia MB, Mwangi M, Ngugi B, Behute MG, Kering K, Agampodi S, Kanungo S, Liu X, Pollard AJ, Zaman K, Kim DR, Kariuki S, Qadri F, Clemens JD. Evaluation of naturally occurring IgG anti-Vi antibody titers as predictors and correlates of typhoid fever in Dhaka, Bangladesh BMC infectious diseases 25(1):149 2025 [PMID: 39891051]
  12. Wood NA, Gopinath T, Shin K, Marassi FM. In situ NMR reveals a pH sensor motif in an outer membrane protein that drives bacterial vesicle production bioRxiv : the preprint server for biology 2025 [PMID: 39896486]
  13. Petrovsky N, Killeen KP. Progress in the development of an Advax-adjuvanted protein capsular matrix vaccine against typhoid fever Microbes & immunity 2(1):92-9100 2025 [PMID: 39911309]

Shigella

  1. Liao Y-S, Chen B-H, Hong Y-P, Wang Y-W, Teng R-H, Liang S-Y, Chang J-H, Tsao C-S, Wei HL, Chiou C-S. The rise in domestic shigellosis and the genomic characteristics of Shigella clones linked to men who have sex with men in Taiwan, 2015‒2022 Microbiology spectrum :e0229024 2025 [PMID: 39945556]
  2. Sherman ME, Michalski J, Das S, Yang H, Chandrasekaran L, O'Meara TR, Dowling DJ, Levy O, Barnoy S, Venkatesan M, Ernst RK. BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in mice Vaccine 50:126779 2025 [PMID: 39946867]
  3. Walker RI. Conserved antigens for enteric vaccines Vaccine 50:126828 2025 [PMID: 39914256]
  4. Ongadi BA, Aziz AB, Mbae CK, Mwangi M, Kering K, Khan AI, Nasrin D, Ngugi B, Bundi MM, Park SE, Islam MT, Rickett NY, Ahmmed F, Chowdhury F, Khanam F, Firoj MG, Im J, Haile K, Ara SI, Behute MG, Agampodi S, Akter A, Kanungo S, Zaman K, Qadri F, Clemens JD, Kariuki S. Shigellosis in an Urban Slum in Kenya: Risk Factors and Antimicrobial Resistance Open forum infectious diseases 12(2):ofaf026 2025 [PMID: 39963694]

Staphylococcal enterotoxin B

  1. Xu L, Yu Z, Xu Y, Wang Q, Wang G, Li B, Weng Q, Yi Y, Li J. An mRNA vaccine candidate encoding cholera toxin subunit B and conserved antigens of influenza viruses confers cross-protection against influenza a viruses in adult and aged mice Human vaccines & immunotherapeutics 21(1):2453304 2025 [PMID: 39957235]
  2. Liu J, Jokiranta TS, Carlin N, Stroup S, Zhang J, Sjostrand B, Svennerholm A-M, Houpt ER, Kantele A. Use of a TaqMan Array Card for identification of enterotoxins and colonization factors directly from stool samples in an enterotoxigenic E. coli vaccine study Microbiology spectrum :e0187024 2025 [PMID: 39932427]

Variola major (Smallpox)

  1. Hou W, Wu N, Liu Y, Tang Y, Quan Q, Luo Y, Jin C. Mpox: Global epidemic situation and countermeasures Virulence 16(1):2457958 2025 [PMID: 39921615]
  2. Mojgani N, Ashique S, Moradi M, Bagheri M, Garg A, Kaushik M, Hussain MS, Yasmin S, Ansari MY. Gut Microbiota and Postbiotic Metabolites: Biotic Intervention for Enhancing Vaccine Responses and Personalized Medicine for Disease Prevention Probiotics and antimicrobial proteins 2025 [PMID: 39964413]
  3. MacIntyre CR. Thinking globally for pandemic early warning systems Nature medicine 2025 [PMID: 39939525]
  4. Mishra SK, Chandra A, Mitra N, Krishna N, Singh N, Akash S, Jardan YAB, Bourhia M, Georrge JJ. Exploring the Dynamics of Asparagus racemosus Phytochemicals as Dual Target Inhibitors of Monkeypox Virus Current medicinal chemistry 2025 [PMID: 39931982]
  5. Bellotti BR, Díaz EW, De la Puente-León M, Rieders MT, Recuenco SE, Levy MZ, Castillo-Neyra R. Challenging a paradigm: Staggered versus single-pulse mass dog vaccination strategy for rabies elimination PLoS computational biology 21(2):e1012780 2025 [PMID: 39919100]
  6. Ukonaho S, Lummaa V, Briga M. Socioeconomic Differences in Vaccination Coverage After a Mandatory Vaccination Law, 1855-1900 JAMA network open 8(2):e2460558 2025 [PMID: 39969881]
  7. Ugwu CLJ, Bragazzi NL, Wu J, Kong JD, Asgary A, Orbinski J, Woldegerima WA. Risk factors associated with human Mpox infection: a systematic review and meta-analysis BMJ global health 10(2) 2025 [PMID: 39900427]
  8. Halder SK, Sultana A, Himel MK, Shil A. Monkeypox: Origin, Transmission, Clinical Manifestations, Prevention, and Therapeutic Options Interdisciplinary perspectives on infectious diseases 2025:2522741 2025 [PMID: 39950190]
  9. Liu WD, Chao TL, Chen KH, Sun HY, Lin KY, Chuang YC, Huang YS, Lin CY, Hsu WT, Huang CF, Li GC, Liu WC, Wu CH, Su YC, Chang LH, Lin CY, Wu PY, Chen LY, Chen YT, Luo YZ, Chang HY, Chen YC, Yao Y, Wang JT, Sheng WH, Hsieh SM, Chang SC, Chang SY, Hung CC. Short-term evolution of Mpox-specific IgG and neutralizing antibodies among individuals undergoing MVA-BN vaccination International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases :107830 2025 [PMID: 39894441]
  10. Chen Z, Jiang Y, Cui J, Li W, Han W, Liu G. Elucidating the Mechanism of VVTT Infection Through Machine Learning and Transcriptome Analysis International journal of molecular sciences 26(3) 2025 [PMID: 39940969]
  11. Vigezzi GP, Vecchio R, Barbati C, Bonazza G, Mazzarello P, Odone A. Historical analysis of the first smallpox vaccination campaigns in early 19-century northern Italy: organisation and communication insights for contemporary epidemics' prevention and control Vaccine 49:126764 2025 [PMID: 39889535]
  12. Mohamad Javier R, Prijanto SA, Yora VS, Yuliana Eka Pratiwi DG, Lilhawa Ditsi ES, Adelia B, Tansuri VC, Wijaya H, Caecarma GY, Damayanti IT, Ramadhanti A, Rahmaputri A, Albab CF, Ferdian A, Farabi F, Ayu FR, Ika Regina Maharani NP, Arifin AP, Herwanto ES, A SR, Arviana SD, Lathifah SN, Yulinar NR, Safitri LS, Adnani B, Fazrian Danu MR, Naomi N, Deria DD, Syifa A, Andana P, Prasetya A, Agfata FR, Margaretha MC, Indrasto SB, Sukirman, Rachmanto, Nufus H, Chandrawati PF, Prasetyo AD, Sutanto L, Sander MA. Systematic review: characteristics of myocarditis followed by fixed drug eruption and dry eye syndrome in patients who have been vaccinated with monkeypox in children and adults Frontiers in cardiovascular medicine 11:1505298 2024 [PMID: 39944657]
  13. Aryaloka S, Khairullah AR, Kusala MKJ, Fauziah I, Hidayatik N, Agil M, Yuliani MGA, Novianti AN, Moses IB, Purnama MTE, Wibowo S, Fauzia KA, Raissa R, Furqoni AH, Awwanah M, Riwu KHP. Navigating monkeypox: identifying risks and implementing solutions Open veterinary journal 14(12):3144-3163 2024 [PMID: 39927376]
  14. Aghabeiglooei Z, Rezaei Orimi J, Marghoub Khajeh S, Mojahedi M, Ghaffari F. Consequences of Infectious Disease Outbreaks in Ardabil (1925-1941): A Historical Analysis Archives of Iranian medicine 27(12):710-717 2024 [PMID: 39891460]

Venezuelan equine encephalitis virus

  1. Hamer MJ, McCarty JM, Pierson BC, Regules JA, Mendy J, Sanborn AD, Gardner CL, Haller JM, Gregory MK, Liggett DL, Glass PJ, Ghosh N, Royalty Tredo S, Warfield KL, Burke CW, Lee C, Saunders D, Bedell L, Richardson JS. Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled study The Lancet. Microbe :101000 2025 [PMID: 39954701]

Vibrio cholerae

  1. Khairunisa SQ, Rachman BE, Nasronudin, Fahmi M, Dinana IA, Ito M. Designing a multi-epitope vaccine targeting the HIV-1 subtype CRF01_AE in Indonesia Computers in biology and medicine 187:109758 2025 [PMID: 39889449]
  2. Khanam F, Islam MT, Ahmmed F, Rajib MNH, Hossen MI, Chowdhury F, Khan AI, Bhuiyan MTR, Haque S, Biswas PK, Bhuiyan AI, Khan ZH, Amin MA, Rahman A, Rizvi SMS, Shirin T, Islam MN, Tiffany A, Breakwell L, Qadri F, Clemens JD. Evaluation of oral cholera vaccine (Euvichol-Plus) effectiveness against Vibrio cholerae in Bangladesh: an interim analysis BMJ global health 10(2) 2025 [PMID: 39900426]
  3. Stout RC, Feasey N, Péchayre M, Thomson N, Chilima BZ. Time to invest in cholera EClinicalMedicine 80:103044 2025 [PMID: 39896879]

Yersinia pestis (Plague)

  1. Derbise A, Guillas C, Echenique-Rivera H, Carniel E, Gerke C, Pizarro-Cerdá J, Demeure CE. Contribution of the type 3 secretion system to adaptive and innate immunity induced by a live Yersinia pseudotuberculosis plague vaccine Vaccine 51:126887 2025 [PMID: 39978224]
  2. Zampieri F, Michieletto F, Zanatta A. Rise and fall of the Myth of the Good Pathogen in Evolutionary Biology and Medicine International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases :107836 2025 [PMID: 39921082]
  3. Kluemper A, Morris K, Mellon MJ. From plague to the promise: The journey of Bacille Calmette-Guérin Bladder (San Francisco, Calif.) 11(4):e21200022 2024 [PMID: 39944512]

Click HERE to see the publications in the last month.